STOWERS INSTITUTE FOR MEDICAL RESEARCH: Form 990, tax year 2019

View the entire original 990 at ProPublica ↗

Organization
STOWERS INSTITUTE FOR MEDICAL RESEARCH (EIN 20-2993509)
Tax period
2019-01-01 to 2019-12-31
Filed
2020-08-17
IRS object ID
202002309349303250
Schema version
2019v5.1
Source
Download XML · Original 990 at ProPublica

Every field in the e-filed return. Faint text is the IRS element name, for citing.

Return header ReturnHeader

FieldValueIRS element (for citing)
Return2020-08-17T14:54:48-05:00ReturnTs
Tax Period End2019-12-31TaxPeriodEndDt

Preparer Firm PreparerFirmGrp

Preparer Firm Name PreparerFirmName

FieldValueIRS element (for citing)
Business Name Line1PRICEWATERHOUSECOPPERS LLPBusinessNameLine1Txt

Preparer US Address PreparerUSAddress

FieldValueIRS element (for citing)
Address Line1600 13TH ST NW STE 1000AddressLine1Txt
CityWASHINGTONCityNm
State AbbreviationDCStateAbbreviationCd
ZIP20005ZIPCd
FieldValueIRS element (for citing)
Return Type990ReturnTypeCd
Tax Period Begin2019-01-01TaxPeriodBeginDt

Filer Filer

FieldValueIRS element (for citing)
EIN202993509EIN

Business Name BusinessName

FieldValueIRS element (for citing)
Business Name Line1STOWERS INSTITUTE FOR MEDICAL RESEARCHBusinessNameLine1Txt
FieldValueIRS element (for citing)
In Care Of% KATY GRAHAMInCareOfNm
Business Name ControlSTOWBusinessNameControlTxt
Phone8169264000PhoneNum

US Address USAddress

FieldValueIRS element (for citing)
Address Line11000 EAST 50TH STREETAddressLine1Txt
CityKANSAS CITYCityNm
State AbbreviationMOStateAbbreviationCd
ZIP64110ZIPCd

Business Officer BusinessOfficerGrp

FieldValueIRS element (for citing)
PersonDAVID M CHAOPersonNm
Person TitlePRESIDENTPersonTitleTxt
Phone8169264000PhoneNum
Signature2020-08-12SignatureDt
Discuss With Paid PreparerYes (true)DiscussWithPaidPreparerInd

Preparer Person PreparerPersonGrp

FieldValueIRS element (for citing)
Preparer PersonMICHELLE MICHALOWSKIPreparerPersonNm
PTINP00755304PTIN
Phone2024141000PhoneNum
Preparation2020-08-11PreparationDt

Filing Security Information FilingSecurityInformation

IP Address IPAddress

FieldValueIRS element (for citing)
I Pv4 Address155.201.35.69IPv4AddressTxt
FieldValueIRS element (for citing)
Federal Original Submission Id52580220202305000001FederalOriginalSubmissionId
Federal Original Submission Id2020-08-17FederalOriginalSubmissionIdDt
Filing License TypePFilingLicenseTypeCd
At Submission Creation Device Id5D86657B04133EFD86B5B0998D71DEAD23A9772AAtSubmissionCreationDeviceId
At Submission Filing Device IdC5BA7EE6C872918F72B1E375EC55F547D8B64602AtSubmissionFilingDeviceId
FieldValueIRS element (for citing)
Tax2019TaxYr
Build TS2020-09-23 17:36:50ZBuildTS

Form 990 IRS990

FieldValueIRS element (for citing)
Principal OfficerDAVID M CHAOPrincipalOfficerNm

US Address USAddress

FieldValueIRS element (for citing)
Address Line11000 EAST 50TH STREETAddressLine1Txt
CityKANSAS CITYCityNm
State AbbreviationMOStateAbbreviationCd
ZIP64110ZIPCd
FieldValueIRS element (for citing)
Gross Receipts$168,628,194GrossReceiptsAmt
Group Return For AffiliatesfalseGroupReturnForAffiliatesInd
Organization501c3Yes (X)Organization501c3Ind
Website AddressWWW.STOWERS.ORGWebsiteAddressTxt
Type Of Organization CorpYes (X)TypeOfOrganizationCorpInd
Formation2005FormationYr
Legal Domicile StateDELegalDomicileStateCd
Activity Or MissionSIMR'S EXEMPT PURPOSE IS TO PERFORM MEDICAL RESEARCH IN THE PUBLIC INTEREST WITH THE GOAL OF EXPANDING OUR UNDERSTANDING OF THE FUNDAMENTAL PROCESSES OF LIVING CELLS.ActivityOrMissionDesc
Voting Members Governing Body8VotingMembersGoverningBodyCnt
Voting Members Independent3VotingMembersIndependentCnt
Total Employee374TotalEmployeeCnt
Total Volunteers3TotalVolunteersCnt
Total Gross UBI$0TotalGrossUBIAmt
PY Contributions Grants$85,419,816PYContributionsGrantsAmt
CY Contributions Grants$69,501,308CYContributionsGrantsAmt
PY Program Service Revenue$256,571PYProgramServiceRevenueAmt
CY Program Service Revenue$174,675CYProgramServiceRevenueAmt
PY Investment Income$739,516PYInvestmentIncomeAmt
CY Investment Income$2,937,748CYInvestmentIncomeAmt
PY Other Revenue$108,655PYOtherRevenueAmt
CY Other Revenue$835,747CYOtherRevenueAmt
PY Total Revenue$86,524,558PYTotalRevenueAmt
CY Total Revenue$73,449,478CYTotalRevenueAmt
PY Grants And Similar Paid$975,000PYGrantsAndSimilarPaidAmt
CY Grants And Similar Paid$0CYGrantsAndSimilarPaidAmt
PY Benefits Paid To Members$0PYBenefitsPaidToMembersAmt
CY Benefits Paid To Members$0CYBenefitsPaidToMembersAmt
PY Salaries Comp Emp Bnft Paid$34,934,899PYSalariesCompEmpBnftPaidAmt
CY Salaries Comp Emp Bnft Paid$36,569,659CYSalariesCompEmpBnftPaidAmt
PY Total Prof Fndrsng Expns$0PYTotalProfFndrsngExpnsAmt
CY Total Prof Fndrsng Expns$0CYTotalProfFndrsngExpnsAmt
CY Total Fundraising Expense$0CYTotalFundraisingExpenseAmt
PY Other Expenses$50,028,333PYOtherExpensesAmt
CY Other Expenses$55,133,761CYOtherExpensesAmt
PY Total Expenses$85,938,232PYTotalExpensesAmt
CY Total Expenses$91,703,420CYTotalExpensesAmt
PY Revenues Less Expenses$586,326PYRevenuesLessExpensesAmt
CY Revenues Less Expenses-$18,253,942CYRevenuesLessExpensesAmt
Total Assets BOY$335,909,539TotalAssetsBOYAmt
Total Assets EOY$312,071,612TotalAssetsEOYAmt
Total Liabilities BOY$106,170,867TotalLiabilitiesBOYAmt
Total Liabilities EOY$101,229,740TotalLiabilitiesEOYAmt
Net Assets Or Fund Balances BOY$229,738,672NetAssetsOrFundBalancesBOYAmt
Net Assets Or Fund Balances EOY$210,841,872NetAssetsOrFundBalancesEOYAmt
Info In Schedule O Part IIIYes (X)InfoInScheduleOPartIIIInd
MissionSEE SCHEDULE OMissionDesc
Significant New Program SrvcfalseSignificantNewProgramSrvcInd
Significant ChangefalseSignificantChangeInd
Expense$82,661,647ExpenseAmt
Revenue$174,675RevenueAmt
DescSIMR'S ACCOMPLISHMENTS ARE DESCRIBED IN SCHEDULE O.Desc
Total Program Service Expenses$82,661,647TotalProgramServiceExpensesAmt
Described In Section501c3Yes (true)DescribedInSection501c3Ind
Schedule B RequiredYes (true)ScheduleBRequiredInd
Political Campaign ActyfalsePoliticalCampaignActyInd
Lobbying ActivitiesfalseLobbyingActivitiesInd
Subject To Proxy TaxfalseSubjectToProxyTaxInd
Donor Advised FundfalseDonorAdvisedFundInd
Conservation EasementsfalseConservationEasementsInd
Collections Of ArtfalseCollectionsOfArtInd
Credit CounselingfalseCreditCounselingInd
Donor Rstr Or Quasi EndowmentsYes (true)DonorRstrOrQuasiEndowmentsInd
Report Land Building EquipmentYes (true)ReportLandBuildingEquipmentInd
Report Investments Other SecfalseReportInvestmentsOtherSecInd
Report Program Related InvstfalseReportProgramRelatedInvstInd
Report Other AssetsYes (true)ReportOtherAssetsInd
Report Other LiabilitiesYes (true)ReportOtherLiabilitiesInd
Include FIN48 FootnoteYes (true)IncludeFIN48FootnoteInd
Independent Audit Fincl StmtfalseIndependentAuditFinclStmtInd
Consolidated Audit Fincl StmtYes (true)ConsolidatedAuditFinclStmtInd
School OperatingfalseSchoolOperatingInd
Foreign OfficefalseForeignOfficeInd
Foreign ActivitiesfalseForeignActivitiesInd
More Than5000 K To OrgfalseMoreThan5000KToOrgInd
More Than5000 K To IndividualsfalseMoreThan5000KToIndividualsInd
Professional FundraisingfalseProfessionalFundraisingInd
Fundraising ActivitiesfalseFundraisingActivitiesInd
Gaming ActivitiesfalseGamingActivitiesInd
Operate HospitalfalseOperateHospitalInd
Grants To OrganizationsfalseGrantsToOrganizationsInd
Grants To IndividualsfalseGrantsToIndividualsInd
Schedule J RequiredYes (true)ScheduleJRequiredInd
Tax Exempt BondsfalseTaxExemptBondsInd
Engaged In Excess Benefit TransfalseEngagedInExcessBenefitTransInd
PY Excess Benefit TransfalsePYExcessBenefitTransInd
Loan OutstandingfalseLoanOutstandingInd
Grant To Related PersonfalseGrantToRelatedPersonInd
Business Rln With Org MemfalseBusinessRlnWithOrgMemInd
Business Rln With Fam MemYes (true)BusinessRlnWithFamMemInd
Business Rln With35 Ctrl EntfalseBusinessRlnWith35CtrlEntInd
Deductible Non Cash ContriYes (true)DeductibleNonCashContriInd
Deductible Art ContributionfalseDeductibleArtContributionInd
Terminate OperationsfalseTerminateOperationsInd
Partial LiquidationfalsePartialLiquidationInd
Disregarded EntityfalseDisregardedEntityInd
Related EntityYes (true)RelatedEntityInd
Related Organization Ctrl EntYes (true)RelatedOrganizationCtrlEntInd
Transaction With Control EntYes (true)TransactionWithControlEntInd
Trnsfr Exmpt Non Chrtbl Rltd OrgfalseTrnsfrExmptNonChrtblRltdOrgInd
Activities Conducted PrtshpfalseActivitiesConductedPrtshpInd
Schedule O RequiredYes (true)ScheduleORequiredInd
IRP Document31IRPDocumentCnt
IRP Document W2 G0IRPDocumentW2GCnt
Backup Wthld ComplianceYes (true)BackupWthldComplianceInd
Employee374EmployeeCnt
Employment Tax Returns FiledYes (true)EmploymentTaxReturnsFiledInd
Unrelated Bus Incm Over LimitfalseUnrelatedBusIncmOverLimitInd
Foreign Financial AccountfalseForeignFinancialAccountInd
Prohibited Tax Shelter TransfalseProhibitedTaxShelterTransInd
Taxable Party NotificationfalseTaxablePartyNotificationInd
Nondeductible ContributionsfalseNondeductibleContributionsInd
Quid Pro Quo ContributionsfalseQuidProQuoContributionsInd
Form8282 Property Disposed OffalseForm8282PropertyDisposedOfInd
Rcv Fnds To Pay Prsnl Bnft CntrctfalseRcvFndsToPayPrsnlBnftCntrctInd
Pay Premiums Prsnl Bnft CntrctfalsePayPremiumsPrsnlBnftCntrctInd
Indoor Tanning ServicesfalseIndoorTanningServicesInd
Subj To Tax Rmnrtn Ex Prcht PymtYes (true)SubjToTaxRmnrtnExPrchtPymtInd
Subject To Excs Tax Net Invst IncfalseSubjectToExcsTaxNetInvstIncInd
Info In Schedule O Part VIYes (X)InfoInScheduleOPartVIInd
Governing Body Voting Members8GoverningBodyVotingMembersCnt
Independent Voting Member3IndependentVotingMemberCnt
Family Or Business RlnYes (true)FamilyOrBusinessRlnInd
Delegation Of Mgmt DutiesfalseDelegationOfMgmtDutiesInd
Change To Org DocumentsfalseChangeToOrgDocumentsInd
Material Diversion Or MisusefalseMaterialDiversionOrMisuseInd
Members Or StockholdersfalseMembersOrStockholdersInd
Election Of Board MembersfalseElectionOfBoardMembersInd
Decisions Subject To ApprovafalseDecisionsSubjectToApprovaInd
Minutes Of Governing BodyYes (true)MinutesOfGoverningBodyInd
Minutes Of CommitteesYes (true)MinutesOfCommitteesInd
Officer Mailing AddressfalseOfficerMailingAddressInd
Local ChaptersfalseLocalChaptersInd
Form990 Provided To Gvrn BodyYes (true)Form990ProvidedToGvrnBodyInd
Conflict Of Interest PolicyYes (true)ConflictOfInterestPolicyInd
Annual Disclosure Covered PrsnYes (true)AnnualDisclosureCoveredPrsnInd
Regular Monitoring EnfrcYes (true)RegularMonitoringEnfrcInd
Whistleblower PolicyYes (true)WhistleblowerPolicyInd
Document Retention PolicyYes (true)DocumentRetentionPolicyInd
Compensation Process CEOYes (true)CompensationProcessCEOInd
Compensation Process OtherfalseCompensationProcessOtherInd
Investment In Joint VenturefalseInvestmentInJointVentureInd
Upon RequestYes (X)UponRequestInd

Books In Care Of Detail BooksInCareOfDetail

FieldValueIRS element (for citing)
PersonKATY GRAHAMPersonNm
Phone8169264000PhoneNum

US Address USAddress

FieldValueIRS element (for citing)
Address Line11000 E 50TH STREETAddressLine1Txt
CityKANSAS CITYCityNm
State AbbreviationMOStateAbbreviationCd
ZIP64110ZIPCd
FieldValueIRS element (for citing)
Info In Schedule O Part VIIYes (X)InfoInScheduleOPartVIIInd

Form990 Part VII Section A Form990PartVIISectionAGrp (15 entries)

TitleTitleTxtAverage Hours Per WeekAverageHoursPerWeekRtAverage Hours Per Week Rltd OrgAverageHoursPerWeekRltdOrgRtIndividual Trustee Or DirectorIndividualTrusteeOrDirectorIndOfficerOfficerIndReportable Comp From OrgReportableCompFromOrgAmtReportable Comp From Rltd OrgReportableCompFromRltdOrgAmtOther CompensationOtherCompensationAmtHighest Compensated EmployeeHighestCompensatedEmployeeInd
RICHARD W BROWN
DIRECTOR/CHAIR2.046.0Yes (X)Yes (X)$0$2,543,498$61,830
RODERICK L STURGEON
DIRECTOR/CFO2.048.0Yes (X)Yes (X)$0$1,704,983$64,605
DAVID A WELTE
DIRECTOR/SECRETARY2.048.0Yes (X)Yes (X)$0$1,425,034$70,740
DAVID M CHAO
DIRECTOR/PRESIDENT/CEO40.04.0Yes (X)Yes (X)$1,370,171$0$43,446
ROBERT E KRUMLAUF - T
DIR/SCIENTIFIC DIR EMERITUS40.04.0Yes (X)$631,407$0$63,105
BRENT KREIDER
CHIEF OPERATING OFFICER2.040.0Yes (X)$0$616,652$25,223
R SCOTT HAWLEY
INVESTIGATOR40.02.0$372,647$0$61,908Yes (X)
JERRY L WORKMAN
INVESTIGATOR40.00.0$373,543$0$54,043Yes (X)
JOAN W CONAWAY
INVESTIGATOR40.00.0$311,126$0$61,863Yes (X)
RONALD C CONAWAY
INVESTIGATOR40.00.0$313,193$0$43,446Yes (X)
LINHENG LI
INVESTIGATOR40.00.0$276,038$0$42,317Yes (X)
ALEJANDRO SANCHEZ ALVA
DIR/SCIENTIFIC DIR FROM 7/201940.04.0Yes (X)$154,210$0$16,751
VIRGINIA G STOWERS
DIRECTOR2.02.0Yes (X)$0$0$0
ALBERZINE FREEMAN
DIRECTOR2.04.0Yes (X)$0$0$0
JONATHAN THOMAS
DIRECTOR2.04.0Yes (X)$0$0$0
FieldValueIRS element (for citing)
Total Reportable Comp From Org$3,802,335TotalReportableCompFromOrgAmt
Tot Reportable Comp Rltd Org$6,290,167TotReportableCompRltdOrgAmt
Total Other Compensation$609,277TotalOtherCompensationAmt
Indiv Rcvd Greater Than100 K47IndivRcvdGreaterThan100KCnt
Former Ofcr Employees ListedfalseFormerOfcrEmployeesListedInd
Total Comp Greater Than150 KYes (true)TotalCompGreaterThan150KInd
Compensation From Other SrcsfalseCompensationFromOtherSrcsInd

Contractor Compensation ContractorCompensationGrp (2 entries)

Address Line1ContractorAddress/USAddress/AddressLine1TxtCityContractorAddress/USAddress/CityNmState AbbreviationContractorAddress/USAddress/StateAbbreviationCdZIPContractorAddress/USAddress/ZIPCdServicesServicesDescCompensationCompensationAmt
ETC GROUP LLC
1997 S 1100 ESALT LAKE CITYUT84106SOFTWARE DEVEL SRVCS$242,840
AMERICAN CENTURY INVESTMENTS
4500 MAIN STKANSAS CITYMO64111INDIRECT - SEE SCH O$169,000
FieldValueIRS element (for citing)
Cntrct Rcvd Greater Than100 K2CntrctRcvdGreaterThan100KCnt
Related Organizations$63,100,000RelatedOrganizationsAmt
Government Grants$5,608,271GovernmentGrantsAmt
All Other Contributions$793,037AllOtherContributionsAmt
Noncash Contributions$63,100,000NoncashContributionsAmt
Total Contributions$69,501,308TotalContributionsAmt

Program Service Revenue ProgramServiceRevenueGrp

FieldValueIRS element (for citing)
DescCOLLABORATION FEE FROM HHMI 501(C)(3)Desc
Business900099BusinessCd
Total Revenue Column$174,675TotalRevenueColumnAmt
Related Or Exempt Func Income$174,675RelatedOrExemptFuncIncomeAmt
FieldValueIRS element (for citing)
Total Program Service Revenue$174,675TotalProgramServiceRevenueAmt

Investment Income InvestmentIncomeGrp

FieldValueIRS element (for citing)
Total Revenue Column$1,654,052TotalRevenueColumnAmt
Exclusion$1,654,052ExclusionAmt

Incm From Invest Bond Proceeds IncmFromInvestBondProceedsGrp

FieldValueIRS element (for citing)
Total Revenue Column$0TotalRevenueColumnAmt

Royalties Revenue RoyaltiesRevenueGrp

FieldValueIRS element (for citing)
Total Revenue Column$775,726TotalRevenueColumnAmt
Exclusion$775,726ExclusionAmt

Gross Rents GrossRentsGrp

FieldValueIRS element (for citing)
Real$15,304RealAmt

Less Rental Expenses LessRentalExpensesGrp

FieldValueIRS element (for citing)
Real$15,304RealAmt

Rental Income Or Loss RentalIncomeOrLossGrp

FieldValueIRS element (for citing)
Real$0RealAmt
Personal$0PersonalAmt

Net Rental Income Or Loss NetRentalIncomeOrLossGrp

FieldValueIRS element (for citing)
Total Revenue Column$0TotalRevenueColumnAmt

Gross Amount Sales Assets GrossAmountSalesAssetsGrp

FieldValueIRS element (for citing)
Securities$96,340,208SecuritiesAmt
Other$106,900OtherAmt

Less Cost Oth Basis Sales Expnss LessCostOthBasisSalesExpnssGrp

FieldValueIRS element (for citing)
Securities$95,086,631SecuritiesAmt
Other$76,781OtherAmt

Gain Or Loss GainOrLossGrp

FieldValueIRS element (for citing)
Securities$1,253,577SecuritiesAmt
Other$30,119OtherAmt

Net Gain Or Loss Investments NetGainOrLossInvestmentsGrp

FieldValueIRS element (for citing)
Total Revenue Column$1,283,696TotalRevenueColumnAmt
Exclusion$1,283,696ExclusionAmt
FieldValueIRS element (for citing)
Fundraising Gross Income$0FundraisingGrossIncomeAmt
Fundraising Direct Expenses$0FundraisingDirectExpensesAmt

Net Incm From Fundraising Evt NetIncmFromFundraisingEvtGrp

FieldValueIRS element (for citing)
Total Revenue Column$0TotalRevenueColumnAmt
FieldValueIRS element (for citing)
Gaming Gross Income$0GamingGrossIncomeAmt
Gaming Direct Expenses$0GamingDirectExpensesAmt

Net Income From Gaming NetIncomeFromGamingGrp

FieldValueIRS element (for citing)
Total Revenue Column$0TotalRevenueColumnAmt
FieldValueIRS element (for citing)
Gross Sales Of Inventory$0GrossSalesOfInventoryAmt
Cost Of Goods Sold$0CostOfGoodsSoldAmt

Net Income Or Loss NetIncomeOrLossGrp

FieldValueIRS element (for citing)
Total Revenue Column$0TotalRevenueColumnAmt

Other Revenue Misc OtherRevenueMiscGrp

FieldValueIRS element (for citing)
DescOTHER REBATES & REVENUEDesc
Business900099BusinessCd
Total Revenue Column$60,021TotalRevenueColumnAmt
Exclusion$60,021ExclusionAmt
FieldValueIRS element (for citing)
Other Revenue Total$60,021OtherRevenueTotalAmt

Total Revenue TotalRevenueGrp

FieldValueIRS element (for citing)
Total Revenue Column$73,449,478TotalRevenueColumnAmt
Related Or Exempt Func Income$174,675RelatedOrExemptFuncIncomeAmt
Exclusion$3,773,495ExclusionAmt

Grants To Domestic Orgs GrantsToDomesticOrgsGrp

FieldValueIRS element (for citing)
Total$0TotalAmt

Grants To Domestic Individuals GrantsToDomesticIndividualsGrp

FieldValueIRS element (for citing)
Total$0TotalAmt

Foreign Grants ForeignGrantsGrp

FieldValueIRS element (for citing)
Total$0TotalAmt

Benefits To Members BenefitsToMembersGrp

FieldValueIRS element (for citing)
Total$0TotalAmt

Comp Current Ofcr Directors CompCurrentOfcrDirectorsGrp

FieldValueIRS element (for citing)
Total$2,279,090TotalAmt
Program Services$2,051,181ProgramServicesAmt
Management And General$227,909ManagementAndGeneralAmt
Fundraising$0FundraisingAmt

Comp Disqual Persons CompDisqualPersonsGrp

FieldValueIRS element (for citing)
Total$782,159TotalAmt
Program Services$703,943ProgramServicesAmt
Management And General$78,216ManagementAndGeneralAmt
Fundraising$0FundraisingAmt

Other Salaries And Wages OtherSalariesAndWagesGrp

FieldValueIRS element (for citing)
Total$24,432,159TotalAmt
Program Services$21,988,943ProgramServicesAmt
Management And General$2,443,216ManagementAndGeneralAmt
Fundraising$0FundraisingAmt

Pension Plan Contributions PensionPlanContributionsGrp

FieldValueIRS element (for citing)
Total$2,539,143TotalAmt
Program Services$2,285,229ProgramServicesAmt
Management And General$253,914ManagementAndGeneralAmt

Other Employee Benefits OtherEmployeeBenefitsGrp

FieldValueIRS element (for citing)
Total$4,845,937TotalAmt
Program Services$4,361,343ProgramServicesAmt
Management And General$484,594ManagementAndGeneralAmt
Fundraising$0FundraisingAmt

Payroll Taxes PayrollTaxesGrp

FieldValueIRS element (for citing)
Total$1,691,171TotalAmt
Program Services$1,522,054ProgramServicesAmt
Management And General$169,117ManagementAndGeneralAmt
Fundraising$0FundraisingAmt

Fees For Services Management FeesForServicesManagementGrp

FieldValueIRS element (for citing)
Total$0TotalAmt

Fees For Services Legal FeesForServicesLegalGrp

FieldValueIRS element (for citing)
Total$0TotalAmt

Fees For Services Accounting FeesForServicesAccountingGrp

FieldValueIRS element (for citing)
Total$0TotalAmt

Fees For Services Lobbying FeesForServicesLobbyingGrp

FieldValueIRS element (for citing)
Total$0TotalAmt

Fees For Services Prof Fundraising FeesForServicesProfFundraising

FieldValueIRS element (for citing)
Total$0TotalAmt

Fees For Srvc Invst Mgmnt Fees FeesForSrvcInvstMgmntFeesGrp

FieldValueIRS element (for citing)
Total$0TotalAmt

Fees For Services Other FeesForServicesOtherGrp

FieldValueIRS element (for citing)
Total$1,166,109TotalAmt
Program Services$1,049,498ProgramServicesAmt
Management And General$116,611ManagementAndGeneralAmt

Advertising AdvertisingGrp

FieldValueIRS element (for citing)
Total$0TotalAmt

Office Expenses OfficeExpensesGrp

FieldValueIRS element (for citing)
Total$141,679TotalAmt
Program Services$127,511ProgramServicesAmt
Management And General$14,168ManagementAndGeneralAmt
Fundraising$0FundraisingAmt

Information Technology InformationTechnologyGrp

FieldValueIRS element (for citing)
Total$340,358TotalAmt
Program Services$306,322ProgramServicesAmt
Management And General$34,036ManagementAndGeneralAmt
Fundraising$0FundraisingAmt

Royalties RoyaltiesGrp

FieldValueIRS element (for citing)
Total$386,412TotalAmt
Program Services$347,771ProgramServicesAmt
Management And General$38,641ManagementAndGeneralAmt
Fundraising$0FundraisingAmt

Occupancy OccupancyGrp

FieldValueIRS element (for citing)
Total$2,215,247TotalAmt
Program Services$1,993,722ProgramServicesAmt
Management And General$221,525ManagementAndGeneralAmt
Fundraising$0FundraisingAmt

Travel TravelGrp

FieldValueIRS element (for citing)
Total$891,238TotalAmt
Program Services$802,114ProgramServicesAmt
Management And General$89,124ManagementAndGeneralAmt
Fundraising$0FundraisingAmt

Pymt Travel Entrtnmnt Pub Ofcl PymtTravelEntrtnmntPubOfclGrp

FieldValueIRS element (for citing)
Total$0TotalAmt

Conferences Meetings ConferencesMeetingsGrp

FieldValueIRS element (for citing)
Total$697,978TotalAmt
Program Services$628,180ProgramServicesAmt
Management And General$69,798ManagementAndGeneralAmt
Fundraising$0FundraisingAmt

Interest InterestGrp

FieldValueIRS element (for citing)
Total$0TotalAmt

Payments To Affiliates PaymentsToAffiliatesGrp

FieldValueIRS element (for citing)
Total$0TotalAmt

Depreciation Depletion DepreciationDepletionGrp

FieldValueIRS element (for citing)
Total$9,625,997TotalAmt
Program Services$8,663,397ProgramServicesAmt
Management And General$962,600ManagementAndGeneralAmt
Fundraising$0FundraisingAmt

Insurance InsuranceGrp

FieldValueIRS element (for citing)
Total$0TotalAmt

Other Expenses OtherExpensesGrp (4 entries)

DescDescTotalTotalAmtProgram ServicesProgramServicesAmtManagement And GeneralManagementAndGeneralAmt
COST-SHARING W/RELATED ORG$30,443,614$27,399,253$3,044,361
LAB SUPPLIES$6,590,191$5,931,172$659,019
PER CAPITA APPROP. TO GSSIMR$1,285,700$1,285,700$0
NON-CAPITAL EQUIPMENT$465,867$419,280$46,587

All Other Expenses AllOtherExpensesGrp

FieldValueIRS element (for citing)
Total$883,371TotalAmt
Program Services$795,034ProgramServicesAmt
Management And General$88,337ManagementAndGeneralAmt

Total Functional Expenses TotalFunctionalExpensesGrp

FieldValueIRS element (for citing)
Total$91,703,420TotalAmt
Program Services$82,661,647ProgramServicesAmt
Management And General$9,041,773ManagementAndGeneralAmt
Fundraising$0FundraisingAmt

Cash Non Interest Bearing CashNonInterestBearingGrp

FieldValueIRS element (for citing)
BOY$0BOYAmt
EOY$0EOYAmt

Savings And Temp Cash Invst SavingsAndTempCashInvstGrp

FieldValueIRS element (for citing)
BOY$1,897,970BOYAmt
EOY$937,906EOYAmt

Pledges And Grants Receivable PledgesAndGrantsReceivableGrp

FieldValueIRS element (for citing)
BOY$415,996BOYAmt
EOY$470,714EOYAmt

Accounts Receivable AccountsReceivableGrp

FieldValueIRS element (for citing)
BOY$0BOYAmt
EOY$0EOYAmt

Receivables From Officers Etc ReceivablesFromOfficersEtcGrp

FieldValueIRS element (for citing)
BOY$0BOYAmt
EOY$0EOYAmt

Rcvbl From Disqualified Prsn RcvblFromDisqualifiedPrsnGrp

FieldValueIRS element (for citing)
BOY$0BOYAmt
EOY$0EOYAmt

Oth Notes Loans Receivable Net OthNotesLoansReceivableNetGrp

FieldValueIRS element (for citing)
BOY$0BOYAmt
EOY$0EOYAmt

Inventories For Sale Or Use InventoriesForSaleOrUseGrp

FieldValueIRS element (for citing)
BOY$2,287BOYAmt
EOY$2,627EOYAmt

Prepaid Expenses Defrd Charges PrepaidExpensesDefrdChargesGrp

FieldValueIRS element (for citing)
BOY$330,173BOYAmt
EOY$375,470EOYAmt
FieldValueIRS element (for citing)
Land Bldg Equip Cost Or Other Bss$333,055,015LandBldgEquipCostOrOtherBssAmt
Land Bldg Equip Accum Deprec$194,728,136LandBldgEquipAccumDeprecAmt

Land Bldg Equip Basis Net LandBldgEquipBasisNetGrp

FieldValueIRS element (for citing)
BOY$141,078,865BOYAmt
EOY$138,326,879EOYAmt

Investments Pub Traded Sec InvestmentsPubTradedSecGrp

FieldValueIRS element (for citing)
BOY$101,356,319BOYAmt
EOY$85,997,459EOYAmt

Investments Other Securities InvestmentsOtherSecuritiesGrp

FieldValueIRS element (for citing)
BOY$373,601BOYAmt
EOY$448,431EOYAmt

Investments Program Related InvestmentsProgramRelatedGrp

FieldValueIRS element (for citing)
BOY$0BOYAmt
EOY$0EOYAmt

Intangible Assets IntangibleAssetsGrp

FieldValueIRS element (for citing)
BOY$0BOYAmt
EOY$0EOYAmt

Other Assets Total OtherAssetsTotalGrp

FieldValueIRS element (for citing)
BOY$90,454,328BOYAmt
EOY$85,512,126EOYAmt

Total Assets TotalAssetsGrp

FieldValueIRS element (for citing)
BOY$335,909,539BOYAmt
EOY$312,071,612EOYAmt

Accounts Payable Accr Expnss AccountsPayableAccrExpnssGrp

FieldValueIRS element (for citing)
BOY$7,568,381BOYAmt
EOY$9,773,789EOYAmt

Grants Payable GrantsPayableGrp

FieldValueIRS element (for citing)
BOY$0BOYAmt
EOY$0EOYAmt

Deferred Revenue DeferredRevenueGrp

FieldValueIRS element (for citing)
BOY$202,716BOYAmt
EOY$334,266EOYAmt

Tax Exempt Bond Liabilities TaxExemptBondLiabilitiesGrp

FieldValueIRS element (for citing)
BOY$0BOYAmt
EOY$0EOYAmt

Escrow Account Liability EscrowAccountLiabilityGrp

FieldValueIRS element (for citing)
BOY$0BOYAmt
EOY$0EOYAmt

Loans From Officers Directors LoansFromOfficersDirectorsGrp

FieldValueIRS element (for citing)
BOY$0BOYAmt
EOY$0EOYAmt

Mortg Notes Pybl Scrd Invst Prop MortgNotesPyblScrdInvstPropGrp

FieldValueIRS element (for citing)
BOY$0BOYAmt
EOY$0EOYAmt

Unsecured Notes Loans Payable UnsecuredNotesLoansPayableGrp

FieldValueIRS element (for citing)
BOY$0BOYAmt
EOY$0EOYAmt

Other Liabilities OtherLiabilitiesGrp

FieldValueIRS element (for citing)
BOY$98,399,770BOYAmt
EOY$91,121,685EOYAmt

Total Liabilities TotalLiabilitiesGrp

FieldValueIRS element (for citing)
BOY$106,170,867BOYAmt
EOY$101,229,740EOYAmt
FieldValueIRS element (for citing)
Organization Follows FASB117Yes (X)OrganizationFollowsFASB117Ind

No Donor Restriction Net Assets NoDonorRestrictionNetAssetsGrp

FieldValueIRS element (for citing)
BOY$229,617,951BOYAmt
EOY$210,635,494EOYAmt

Donor Restriction Net Assets DonorRestrictionNetAssetsGrp

FieldValueIRS element (for citing)
BOY$120,721BOYAmt
EOY$206,378EOYAmt

Total Net Assets Fund Balance TotalNetAssetsFundBalanceGrp

FieldValueIRS element (for citing)
BOY$229,738,672BOYAmt
EOY$210,841,872EOYAmt

Tot Liab Net Assets Fund Balance TotLiabNetAssetsFundBalanceGrp

FieldValueIRS element (for citing)
BOY$335,909,539BOYAmt
EOY$312,071,612EOYAmt
FieldValueIRS element (for citing)
Info In Schedule O Part XIYes (X)InfoInScheduleOPartXIInd
Reconcilation Revenue Expnss-$18,253,942ReconcilationRevenueExpnssAmt
Net Unrlzd Gains Losses Invst-$408,356NetUnrlzdGainsLossesInvstAmt
Other Changes In Net Assets-$234,502OtherChangesInNetAssetsAmt
Method Of Accounting AccrualYes (X)MethodOfAccountingAccrualInd
Accountant Compile Or ReviewfalseAccountantCompileOrReviewInd
FS AuditedYes (true)FSAuditedInd

FS Audited Basis FSAuditedBasisGrp

FieldValueIRS element (for citing)
Consolidated Basis Fincl StmtYes (X)ConsolidatedBasisFinclStmtInd
FieldValueIRS element (for citing)
Audit CommitteeYes (true)AuditCommitteeInd
Federal Grant Audit RequiredYes (true)FederalGrantAuditRequiredInd
Federal Grant Audit PerformedYes (true)FederalGrantAuditPerformedInd

Schedule A IRS990ScheduleA

FieldValueIRS element (for citing)
Medical Research OrganizationYes (X)MedicalResearchOrganizationInd

Hospital Name And Address HospitalNameAndAddressGrp

Supported Organization Name SupportedOrganizationName

FieldValueIRS element (for citing)
Business Name Line1SEE SCHEDULE ABusinessNameLine1Txt
FieldValueIRS element (for citing)
CityPART VICityNm
State AbbreviationMAStateAbbreviationCd

Form990 Schedule A Part VI Form990ScheduleAPartVIGrp (2 entries)

Form And Line ReferenceFormAndLineReferenceDescExplanationExplanationTxt
PART I, LINE 4IN 2019, STOWERS INSTITUTE FOR MEDICAL RESEARCH ("SIMR") SCIENTISTS COLLABORATED WITH RESEARCHERS AT 70 NATIONAL AND 50 INTERNATIONAL INSTITUTIONS INCLUDING DOZENS OF HOSPITALS, MEDICAL CENTERS, AND MEDICAL SCHOOLS. MANY OF THESE COLLABORATIONS RESULTED IN DISCOVERIES THAT MERITED PUBLICATION IN LEADING PEER-REVIEWED SCIENTIFIC JOURNALS AND/OR SUCCESSFULLY FUNDED GRANT AWARDS. SIMR CONDUCTS MEDICAL RESEARCH IN CONJUNCTION WITH THE UNIVERSITY OF KANSAS (KU) AND ITS AFFILIATES THE UNIVERSITY OF KANSAS HOSPITAL AUTHORITY AND THE UNIVERSITY OF KANSAS MEDICAL CENTER (KUMC), PURSUANT TO A WRITTEN MEMORANDUM OF UNDERSTANDING. KUMC IS THE ACADEMIC HEALTH SCIENCE CENTER OF THE LARGEST PUBLIC RESEARCH UNIVERSITY IN THE STATE OF KANSAS. KUMC OFFERS PROGRAMS AND SERVICES THAT FOCUS ON EDUCATION, RESEARCH, PATIENT CARE, AND COMMUNITY ENGAGEMENT. AS OF DECEMBER 31, 2019, FIVE KUMC STUDENTS HAVE RECEIVED MS DEGREES AND 45 KUMC STUDENTS HAVE RECEIVED PHD DEGREES FOR THESIS WORK PERFORMED IN SIMR'S LABS. KUMC IS AFFILIATED WITH THE UNIVERSITY OF KANSAS HOSPITAL, A NONPROFIT INDEPENDENT HOSPITAL CO-LOCATED WITH THE MAIN KUMC CAMPUS IN KANSAS CITY, KS. IN 2019, TWENTY SIMR RESEARCH PROGRAM LEADERS WERE ADJUNCT FACULTY IN FOUR KUMC DEPARTMENTS. THESE APPOINTMENTS INCLUDED 12 FULL PROFESSORS, FOUR ASSOCIATE PROFESSORS, AND FOUR ASSISTANT PROFESSORS. IN 2019, 52 OF SIMR'S 74 ORIGINAL RESEARCH PUBLICATIONS INCLUDED BOTH SIMR AND KUMC AFFILIATIONS. ABOUT A DOZEN KUMC STUDENTS PERFORMED PREDOCTORAL RESEARCH IN SIMR LABS IN 2019. SIMR IS ALSO A CONSORTIUM MEMBER OF THE UNIVERSITY OF KANSAS CANCER CENTER AT KUMC, A CANCER RESEARCH AND CARE PARTNERSHIP SPANNING TWO STATES AND INVOLVING COLLABORATION AMONG RESEARCHERS, PHYSICIANS, AND CANCER SUPPORT PROFESSIONALS IN BASIC, TRANSLATIONAL, AND CLINICAL RESEARCH AREAS. IN JUNE 2012, THE NIH'S NATIONAL CANCER INSTITUTE (NCI) NAMED THE UNIVERSITY OF KANSAS CANCER CENTER A NCI-DESIGNATED CANCER CENTER. THE NCI CANCER CENTERS PROGRAM IS A PILLAR OF FEDERAL CANCER RESEARCH EFFORTS AND INTEGRAL TO THE NCI'S PROGRAMS FOR STUDYING, TREATING, AND PREVENTING CANCER. IN KUMC'S APPLICATION TO THE NCI CANCER CENTERS PROGRAM, $4 MILLION OF THE $48 MILLION IN GRANTS CITED IN THE APPLICATION WERE GRANTS THAT HAD BEEN AWARDED TO SIMR INVESTIGATORS. IN 2019, 12 SIMR RESEARCH PROGRAM LEADERS WERE MEMBERS OF THE UNIVERSITY OF KANSAS CANCER CENTER'S CANCER BIOLOGY RESEARCH PROGRAM, INCLUDING LINHENG LI, PHD, WHO SERVES AS CO-LEADER OF THE PROGRAM. IN 2019, SIMR RESEARCH PROGRAM LEADER MICHAEL WASHBURN, PHD, CONTINUED A RESEARCH PROJECT IN COLLABORATION WITH ROY JENSEN, MD, DIRECTOR OF THE UNIVERSITY OF KANSAS CANCER CENTER. THE OVERALL AIM OF THIS RESEARCH EFFORT IS TO DETERMINE HOW CANCER THERAPEUTICS ACT ON PROTEIN NETWORKS IN CELLS AND TISSUES. DR. JENSEN IS A WORLD-RENOWNED EXPERT ON BREAST CANCER AND HOLDS ADDITIONAL POSITIONS AS DIRECTOR, KANSAS MASONIC CANCER RESEARCH INSTITUTE, WILLIAM R. JEWELL DISTINGUISHED KANSAS MASONIC PROFESSOR, AND PROFESSOR OF PATHOLOGY AND LABORATORY MEDICINE, ANATOMY AND CELL BIOLOGY, CANCER BIOLOGY, AND MOLECULAR BIOSCIENCES AT KUMC. THE PROJECT AIMS TO FURTHER EXPLORE THE MECHANISM OF ACTION OF SUBEROYLANILIDE HYDROXAMIC ACID (SAHA), WHICH IS USED AS CHEMOTHERAPY FOR CERTAIN LYMPHOMAS AND IS BEING EVALUATED IN CLINICAL TRIALS FOR OTHER CANCERS. RECENT REPORTS SUGGEST THAT SAHA HAS ADDITIONAL EFFECTS THAT INVOLVE PROTEIN NETWORKS MORE BROADLY, THUS SUGGESTING OTHER POSSIBLE MECHANISMS OF ACTION. RESULTS FROM THIS JOINT RESEARCH EFFORT MAY ENABLE THE FUTURE DEVELOPMENT OF MORE SPECIFIC AND EFFECTIVE HUMAN THERAPEUTICS. THIS PROJECT IS SUPPORTED IN PART BY A NIH GRANT FROM THE NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES. IN 2019, SIMR RESEARCH PROGRAM LEADER LINHENG LI, PHD, CONTINUED A COLLABORATION WITH THE UNIVERSITY OF KANSAS CANCER CENTER AND CHILDREN'S MERCY HOSPITAL, KANSAS CITY, MO, TO INVESTIGATE APPROACHES TO TREAT LEUKEMIA. THIS RESEARCH FOCUSES ON TARGETING CANCER STEM CELLS TO HELP REDUCE THE RECURRENCE OF CANCER AFTER A PATIENT GOES INTO REMISSION. THE COLLABORATION BUILDS ON FOUNDATIONAL RESEARCH FROM THE LI LAB THAT HAS CHARACTERIZED CANCER STEM CELLS AT MOLECULAR AND CELLULAR LEVELS. THIS ONGOING RESEARCH COLLABORATION HAS GENERATED FINDINGS THAT HAVE BEEN REPORTED IN ORIGINAL RESEARCH PUBLICATIONS INCLUDING ZHAO M ET AL, 2019. KUMC IS THE SPONSOR OF A RELATED CLINICAL RESEARCH STUDY, "LOW-DOSE DAUNORUBICIN IN PATIENTS WITH RELAPSED/REFRACTORY ACUTE LEUKEMIA," WHICH IS DESIGNED TO ASSESS THE FEASIBILITY AND TOLERABILITY OF ADMINISTERING A LOW DOSE OF THE DRUG TO PATIENTS WITH RELAPSED OR REFRACTORY ACUTE MYELOID LEUKEMIA (AML) OR ACUTE LYMPHOBLASTIC LEUKEMIA (ALL), AND TO OBTAIN PRELIMINARY DATA ON THE DRUG ENGAGING ITS TARGET. SIMR PARTICIPATED IN COLLABORATIONS CONDUCTING RESEARCH IN CONJUNCTION WITH THE FOLLOWING US HOSPITALS, PURSUANT TO AN UNDERSTANDING TO MAINTAIN CONTINUING CLOSE COOPERATION IN THE ACTIVE CONDUCT OF MEDICAL RESEARCH IN 2019: INSTITUTION LOCATION BRIGHAM AND WOMEN'S HOSPITAL BOSTON, MA CHILDREN'S HOSPITAL OF PHILADELPHIA PHILADELPHIA, PA CHILDREN'S MERCY HOSPITAL KANSAS CITY, MO CINCINNATI CHILDREN'S HOSPITAL MEDICAL CENTER CINCINNATI, OH DANA-FARBER CANCER INSTITUTE BOSTON, MA FRED HUTCHINSON CANCER RESEARCH CENTER SEATTLE, WA GEORGE WASHINGTON UNIVERSITY SCHOOL OF MEDICINE AND HEALTH SCIENCES WASHINGTON, DC GREATER BALTIMORE MEDICAL CENTER TOWSON, MD HARVARD MEDICAL SCHOOL BOSTON, MA JOHNS HOPKINS SCHOOL OF MEDICINE BALTIMORE, MD NEW YORK UNIVERSITY SCHOOL OF MEDICINE NEW YORK, NY NORTHWESTERN UNIVERSITY FEINBERG SCHOOL OF MEDICINE CHICAGO, IL OREGON HEALTH AND SCIENCE UNIVERSITY SCHOOL OF MEDICINE PORTLAND, OR PERLMUTTER CANCER CENTER NEW YORK, NY SAINT LOUIS UNIVERSITY SCHOOL OF MEDICINE ST LOUIS, MO SEATTLE CHILDREN'S HOSPITAL SEATTLE, WA SINAI HOSPITAL OF BALTIMORE BALTIMORE, MD STANFORD UNIVERSITY SCHOOL OF MEDICINE PALO ALTO, CA UNIVERSITY OF CALIFORNIA LOS ANGELES DAVID GEFFEN SCHOOL OF MEDICINE LOS ANGELES, CA UNIVERSITY OF CALIFORNIA SAN FRANCISCO SAN FRANCISCO, CA UNIVERSITY OF KANSAS CANCER CENTER KANSAS CITY, KS UNIVERSITY OF KANSAS MEDICAL CENTER KANSAS CITY, KS UNIVERSITY OF PENNSYLVANIA PERELMAN SCHOOL OF MEDICINE PHILADELPHIA, PA UNIVERSITY OF PITTSBURGH CANCER INSTITUTE PITTSBURGH, PA UNIVERSITY OF ROCHESTER MEDICAL CENTER ROCHESTER, NY UNIVERSITY OF SOUTH CAROLINA SCHOOL OF MEDICINE COLUMBIA, SC UNIVERSITY OF TENNESSEE HEALTH SCIENCE CENTER MEMPHIS, TN UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER HOUSTON, TX WEILL CORNELL MEDICINE NEW YORK, NY TO CARRY OUT THE RESEARCH DESCRIBED IN THE FOLLOWING EXAMPLES, SIMR AND HOSPITAL, MEDICAL CENTER, OR MEDICAL SCHOOL ENTERED INTO A COOPERATION AGREEMENT PURSUANT TO WHICH THEY AGREED TO ESTABLISH, DEVELOP, ADMINISTER, AND MAINTAIN CONTINUING CLOSE COOPERATION IN THE ACTIVE CONDUCT OF MEDICAL RESEARCH, INCLUDING THROUGH SPECIFIC COOPERATIVE EFFORTS IN THE AREAS OF RESEARCH, SHARING OF INFORMATION, PURSUANT OF JOINT GRANTS, INTERACTION OF STAFF, ADJUNCT/JOINT APPOINTMENTS, AND SHARING OF FACILITIES. IN ORDER TO ASSURE THE SUCCESS OF THEIR COOPERATIVE RELATIONSHIP, EACH AGREED TO ENGAGE IN EFFECTIVE, COORDINATED AND ONGOING PLANNING, OVERSIGHT, AND COMMUNICATION, AND TO COMMIT THE NECESSARY RESOURCES, BOTH HUMAN AND MONETARY, TO SUPPORT, FACILITATE, AND PROMOTE THE COOPERATION.
JOINT MEDICAL RESEARCH ON THE CHARACTERIZATION OF INTESTINAL STEM CELLS -THE LI LAB PERFORMED JOINT MEDICAL RESEARCH ON THE CHARACTERIZATION OF INTESTINAL STEM CELLS WITH COLLABORATORS AT CINCINNATI CHILDREN'S HOSPITAL MEDICAL CENTER, DAVID GEFFEN SCHOOL OF MEDICINE AT UCLA, OREGON HEALTH AND SCIENCE UNIVERSITY SCHOOL OF MEDICINE, STANFORD UNIVERSITY SCHOOL OF MEDICINE, AND UNIVERSITY OF PITTSBURGH CANCER INSTITUTE. INTESTINAL DISEASES RANGING FROM CROHN'S DISEASE TO COLITIS TO CANCER MAY BENEFIT FROM INTESTINAL STEM CELL THERAPIES. THIS RESEARCH ADVANCES THE UNDERSTANDING OF THE BIOLOGY OF STEM CELLS THAT RESIDE IN THE INTESTINE AND EXPLORES HOW THEY CAN BE USED TO TREAT AND CURE INTESTINAL DISEASES. THIS ONGOING RESEARCH COLLABORATION IS SUPPORTED IN PART BY A NIH GRANT AWARDED BY THE NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES. JOINT MEDICAL RESEARCH ON EYE DEVELOPMENT AND FUNCTION - THE XIE LAB PERFORMED JOINT MEDICAL RESEARCH ON GENETIC PROGRAMS THAT REGULATE THE MAMMALIAN EYE WITH COLLABORATORS AT CINCINNATI CHILDREN'S HOSPITAL MEDICAL CENTER, UNIVERSITY OF ROCHESTER MEDICAL CENTER, AND KYOTO UNIVERSITY. AN EYE STRUCTURE CALLED THE CILIARY BODY IS IMPORTANT FOR CHANGING THE SHAPE OF THE LENS AND FOR PRODUCTION OF THE AQUEOUS HUMOR, THE FLUID THAT MAINTAINS PRESSURE IN THE EYE. DEFECTS IN LENS ACCOMMODATION LEAD TO MYOPIA OR NEARSIGHTEDNESS, WHILE HIGH PRESSURE WITHIN THE EYE IS ONE OF THE MOST IMPORTANT RISK FACTORS FOR GLAUCOMA, THE SECOND LEADING BLIND-CAUSING DISEASE. THE GOAL OF THIS RESEARCH IS TO REVEAL THE MECHANISMS REGULATING THE DEVELOPMENT AND SECRETION OF THE CILIARY BODY. KNOWLEDGE GAINED FROM THESE STUDIES MAY ENHANCE TREATMENTS FOR GLAUCOMA AND MYOPIA. THIS RESEARCH IS SUPPORTED IN PART BY A NIH GRANT FROM THE NATIONAL EYE INSTITUTE. OTHER US COLLABORATORS INCLUDED BERNICE PAUAHI BISHOP MUSEUM, BOSTON COLLEGE, CALIFORNIA INSTITUTE OF TECHNOLOGY, COLD SPRING HARBOR LABORATORY, CORNELIA DE LANGE SYNDROME FOUNDATION, ELMHURST COLLEGE, FLORIDA ATLANTIC UNIVERSITY, HOWARD HUGHES MEDICAL INSTITUTE, INDIANA UNIVERSITY, JOHNS HOPKINS UNIVERSITY, LAWRENCE BERKELEY LABORATORY, MARQUETTE UNIVERSITY, MILLERSVILLE UNIVERSITY, MORGRIDGE INSTITUTE FOR RESEARCH, NATIONAL CANCER INSTITUTE OF THE NATIONAL INSTITUTES OF HEALTH, NATURAL HISTORY MUSEUM OF LOS ANGELES COUNTY, NEW YORK STATE DEPARTMENT OF HEALTH, NEW YORK UNIVERSITY, OPEN UNIVERSITY, PRINCETON UNIVERSITY, PURDUE UNIVERSITY, RUTGERS UNIVERSITY, SOUTHEASTERN LOUISIANA UNIVERSITY, UNIVERSITY OF CALIFORNIA DAVIS, UNIVERSITY OF CALIFORNIA IRVINE, UNIVERSITY OF CALIFORNIA MERCED, UNIVERSITY OF CALIFORNIA SAN DIEGO, UNIVERSITY OF FLORIDA ST AUGUSTINE, UNIVERSITY OF FLORIDA GAINESVILLE, UNIVERSITY OF KANSAS, UNIVERSITY OF KENTUCKY, UNIVERSITY OF MARYLAND, UNIVERSITY OF MINNESOTA, UNIVERSITY OF MISSOURI-KANSAS CITY, UNIVERSITY OF PITTSBURGH, UNIVERSITY OF TEXAS AT ARLINGTON, UNIVERSITY OF VIRGINIA, UNIVERSITY OF WASHINGTON, UNIVERSITY OF WISCONSIN-MADISON, VIRGINIA COMMONWEALTH UNIVERSITY, AND WASHINGTON UNIVERSITY IN ST LOUIS. SIMR COLLABORATED WITH THE FOLLOWING INTERNATIONAL HOSPITALS, MEDICAL CENTERS, AND MEDICAL SCHOOLS IN 2019: BEIJING PERFECT FAMILY HOSPITAL, CHINA; CHINESE ACADEMY OF MEDICAL SCIENCES, TIANJIN, CHINA; HENAN PROVINCIAL PEOPLE'S HOSPITAL, ZHENGZHOU, CHINA; HONG KONG BAPTIST UNIVERSITY, CHINA; HONG KONG UNIVERSITY OF SCIENCE AND TECHNOLOGY, CHINA; PEKING UNION MEDICAL COLLEGE, TIANJIN, CHINA; THIRD AFFILIATED HOSPITAL OF SUN YAT-SEN UNIVERSITY, GUANGZHOU, CHINA; TIANJIN MEDICAL UNIVERSITY, HEPING, CHINA; TSINGHUA UNIVERSITY SCHOOL OF MEDICINE,BEIJING, CHINA; WUHAN NO.1 HOSPITAL, HUBEI, CHINA; AND ZHEJIANG UNIVERSITY SCHOOL OF MEDICINE, HANGZHOU, CHINA. OTHER INTERNATIONAL COLLABORATORS INCLUDED AGENCY FOR SCIENCE, TECHNOLOGY AND RESEARCH, SINGAPORE; BARCELONA INSTITUTE OF SCIENCE AND TECHNOLOGY, SPAIN; CARDIFF UNIVERSITY, CATHAYS, UNITED KINGDOM; CENTRO DE INVESTIGACION BIOMEDICA EN RED EN BIOINGENIERIA, MADRID, SPAIN; CIENCIAS BIOLOGICAS, QUITO, ECUADOR; CZECH ACADEMY OF SCIENCES, PRAGUE; DURHAM UNIVERSITY, UNITED KINGDOM; ECOLE POLYTECHNIQUE, PALAISEAU, FRANCE; FRIEDRICH MIESCHER LABORATORY OF THE MAX PLANCK SOCIETY, TUBINGEN, GERMANY; HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY, WUHAN, HUBEI, CHINA; HUBEI UNIVERSITY, WUHAN, CHINA; INSTITUTO DE FISIOLOGIA, MENDOZA, ARGENTINA; INSTITUTO DE HISTOLOGIA Y EMBRIOLOGIA, MENDOZA, ARGENTINA; INTERNATIONAL IBERIAN NANOTECHNOLOGY LABORATORY, BRAGA, PORTUGAL; ISRAEL INSTITUTE OF TECHNOLOGY, HAIFA; JILIN UNIVERSITY, CHANGCHUN, CHINA; KIEL UNIVERSITY, GERMANY; KYOTO UNIVERSITY, JAPAN; MAX PLANCK INSTITUTE FOR EVOLUTIONARY BIOLOGY, PLON, GERMANY; MAX PLANCK INSTITUTE OF MOLECULAR CELL BIOLOGY AND GENETICS, DRESDEN, GERMANY; NATIONAL RESEARCH COUNCIL, PISA, ITALY; OSAKA UNIVERSITY, JAPAN; RESEARCH CENTRE FOR MEDICAL GENETICS, MOSCOW, RUSSIA; SEJONG UNIVERSITY, SEOUL, KOREA; SHENZHEN UNIVERSITY, CHINA; SUN YAT-SEN UNIVERSITY, GUANGZHOU, CHINA; TEL AVIV UNIVERSITY, ISRAEL; TOHOKU UNIVERSITY, SENDAI, JAPAN; TSINGHUA UNIVERSITY, BEIJING, CHINA; UNIVERSITY OF HELSINKI, FINLAND; UNIVERSITY OF MILAN, ITALY; UNIVERSITY OF SASKATCHEWAN, SASKATOON, CANADA; UNIVERSITY OF SCIENCE AND TECHNOLOGY, HONG KONG, CHINA; UNIVERSITY OF TOKYO, JAPAN; UNIVERSITY OF TORONTO, CANADA; UNIVERSITY OF WURZBURG, GERMANY; UNIVERSITY OF ZURICH, SWITZERLAND; WELLCOME SANGER INSTITUTE, HINXTON, UNITED KINGDOM; AND YONSEI UNIVERSITY COLLEGE OF DENTISTRY, SEOUL, KOREA.

Schedule B IRS990ScheduleB

Contributor Information ContributorInformationGrp

FieldValueIRS element (for citing)
ContributorRESTRICTEDContributorNum

Contributor Business Name ContributorBusinessName

FieldValueIRS element (for citing)
Business Name Line1RESTRICTEDBusinessNameLine1

Contributor US Address ContributorUSAddress

FieldValueIRS element (for citing)
Address Line1RESTRICTEDAddressLine1
Address Line2RESTRICTEDAddressLine2
CityRESTRICTEDCity
StateRESTRICTEDState
ZIP CodeRESTRICTEDZIPCode
FieldValueIRS element (for citing)
Total ContributionsRESTRICTEDTotalContributionsAmt

Schedule D IRS990ScheduleD

FieldValueIRS element (for citing)
Art Public Exhibition AmountsArtPublicExhibitionAmountsGrp
Held Works ArtHeldWorksArtGrp

CY Endwmt Fund CYEndwmtFundGrp

FieldValueIRS element (for citing)
Beginning Year Balance$120,721BeginningYearBalanceAmt
Contributions$163,200ContributionsAmt
Other Expenditures$77,543OtherExpendituresAmt
End Year Balance$206,378EndYearBalanceAmt

CY Minus1 Yr Endwmt Fund CYMinus1YrEndwmtFundGrp

FieldValueIRS element (for citing)
Beginning Year Balance$550,240BeginningYearBalanceAmt
Contributions$75,000ContributionsAmt
Other Expenditures$504,519OtherExpendituresAmt
End Year Balance$120,721EndYearBalanceAmt

CY Minus2 Yr Endwmt Fund CYMinus2YrEndwmtFundGrp

FieldValueIRS element (for citing)
Beginning Year Balance$626,653BeginningYearBalanceAmt
Contributions$100,000ContributionsAmt
Other Expenditures$176,413OtherExpendituresAmt
End Year Balance$550,240EndYearBalanceAmt

CY Minus3 Yr Endwmt Fund CYMinus3YrEndwmtFundGrp

FieldValueIRS element (for citing)
Beginning Year Balance$39,191BeginningYearBalanceAmt
Contributions$661,216ContributionsAmt
Other Expenditures$73,754OtherExpendituresAmt
End Year Balance$626,653EndYearBalanceAmt

CY Minus4 Yr Endwmt Fund CYMinus4YrEndwmtFundGrp

FieldValueIRS element (for citing)
Beginning Year Balance$0BeginningYearBalanceAmt
Contributions$100,000ContributionsAmt
Other Expenditures$60,809OtherExpendituresAmt
End Year Balance$39,191EndYearBalanceAmt
FieldValueIRS element (for citing)
Term Endowment Balance EOY1.00000TermEndowmentBalanceEOYPct
Endowments Held Unrelated OrgfalseEndowmentsHeldUnrelatedOrgInd
Endowments Held Related OrgfalseEndowmentsHeldRelatedOrgInd

Land LandGrp

FieldValueIRS element (for citing)
Other Cost Or Other Basis$3,400,000OtherCostOrOtherBasisAmt
Book Value$3,400,000BookValueAmt

Buildings BuildingsGrp

FieldValueIRS element (for citing)
Other Cost Or Other Basis$232,820,072OtherCostOrOtherBasisAmt
Depreciation$115,655,967DepreciationAmt
Book Value$117,164,105BookValueAmt
FieldValueIRS element (for citing)
Leasehold ImprovementsLeaseholdImprovementsGrp

Equipment EquipmentGrp

FieldValueIRS element (for citing)
Other Cost Or Other Basis$95,244,723OtherCostOrOtherBasisAmt
Depreciation$79,072,169DepreciationAmt
Book Value$16,172,554BookValueAmt

Other Land Buildings OtherLandBuildingsGrp

FieldValueIRS element (for citing)
Other Cost Or Other Basis$1,590,220OtherCostOrOtherBasisAmt
Book Value$1,590,220BookValueAmt
FieldValueIRS element (for citing)
Total Book Value Land Buildings$138,326,879TotalBookValueLandBuildingsAmt

Other Assets Org OtherAssetsOrgGrp (2 entries)

DescDescBook ValueBookValueAmt
ANNUITY REC. FROM AFFILIATE$85,435,085
OTHER RECEIVABLES$77,041
FieldValueIRS element (for citing)
Total Book Value Other Assets$85,512,126TotalBookValueOtherAssetsAmt
Federal Income Tax Liability$0FederalIncomeTaxLiabilityAmt

Other Liabilities Org OtherLiabilitiesOrgGrp (4 entries)

DescDescAmtAmt
ADVANCES FROM AFFILIATES$7,243,770
PAYABLE FOR GIFT ANNUITY$83,657,244
PAYABLE TO GSSIMR$32,058
COMPENSATION EXCISE TAX$188,613
FieldValueIRS element (for citing)
Total Liability$91,121,685TotalLiabilityAmt
Footnote TextYes (X)FootnoteTextInd

Supplemental Information Detail SupplementalInformationDetail (2 entries)

Form And Line ReferenceFormAndLineReferenceDescExplanationExplanationTxt
PART V, LINE 4:THE ENDOWMENT IS FROM A SINGLE DONOR TO CONTRIBUTE FUNDING TOWARDS AN ESTABLISHED LECTURE SERIES PROGRAM WHERE SIMR HOSTS SCIENCE SPEAKERS FROM OTHER RESEARCH INSTITUTIONS AND UNIVERSITIES TO ENCOURAGE COLLABORATIVE SCIENCE OPPORTUNITIES WITH TOP SCIENTISTS FROM AROUND THE WORLD.
PART X, LINE 2:FIN 48 FINANCIAL STATEMENT FOOTNOTE FROM THE CONSOLIDATED STATEMENTS OF STOWERS INSTITUTE FOR MEDICAL RESEARCH (THE INSTITUTE) IS AS FOLLOWS: THE INSTITUTE RECOGNIZES THE EFFECT OF INCOME TAX POSITIONS ONLY IF THOSE POSITIONS ARE MORE LIKELY THAN NOT OF BEING SUSTAINED. RECOGNIZED INCOME TAX POSITIONS ARE MEASURED AT THE LARGEST AMOUNT THAT IS GREATER THAN 50% LIKELY OF BEING REALIZED.

Schedule J IRS990ScheduleJ

FieldValueIRS element (for citing)
Idemnification Gross Up PmtsYes (X)IdemnificationGrossUpPmtsInd
Written Policy Ref T And E ExpnssYes (true)WrittenPolicyRefTAndEExpnssInd
Substantiation RequiredYes (true)SubstantiationRequiredInd
Compensation CommitteeYes (X)CompensationCommitteeInd
Independent ConsultantYes (X)IndependentConsultantInd
Written Employment ContractYes (X)WrittenEmploymentContractInd
Compensation SurveyYes (X)CompensationSurveyInd
Board Or Committee ApprovalYes (X)BoardOrCommitteeApprovalInd
Severance PaymentfalseSeverancePaymentInd
Supplemental Nonqual Rtr PlanfalseSupplementalNonqualRtrPlanInd
Equity Based Comp ArrngmfalseEquityBasedCompArrngmInd
Comp Based On Revenue Of Flng OrgYes (true)CompBasedOnRevenueOfFlngOrgInd
Comp Bsd On Rev Related OrgsfalseCompBsdOnRevRelatedOrgsInd
Comp Bsd Net Earns Flng OrgfalseCompBsdNetEarnsFlngOrgInd
Comp Bsd Net Earns Rltd OrgsfalseCompBsdNetEarnsRltdOrgsInd
Any Non Fixed PaymentsfalseAnyNonFixedPaymentsInd
Initial Contract ExceptionfalseInitialContractExceptionInd

Rltd Org Officer Trst Key Empl RltdOrgOfficerTrstKeyEmplGrp (12 entries)

TitleTitleTxtBase Compensation Filing OrgBaseCompensationFilingOrgAmtCompensation Based On Rltd OrgsCompensationBasedOnRltdOrgsAmtBonus Filing OrganizationBonusFilingOrganizationAmountBonus Related OrganizationsBonusRelatedOrganizationsAmtOther Compensation Filing OrgOtherCompensationFilingOrgAmtOther Compensation Rltd OrgsOtherCompensationRltdOrgsAmtDeferred Compensation Flng OrgDeferredCompensationFlngOrgAmtDeferred Comp Rltd OrgsDeferredCompRltdOrgsAmtNontaxable Benefits Filing OrgNontaxableBenefitsFilingOrgAmtNontaxable Benefits Rltd OrgsNontaxableBenefitsRltdOrgsAmtTotal Compensation Filing OrgTotalCompensationFilingOrgAmtTotal Compensation Rltd OrgsTotalCompensationRltdOrgsAmtComp Report Prior990 Filing OrgCompReportPrior990FilingOrgAmtComp Report Prior990 Rltd OrgsCompReportPrior990RltdOrgsAmt
DAVID A WELTE
DIRECTOR/SECRETARY$0$1,368,976$0$0$0$56,058$0$42,000$0$28,740$0$1,495,774$0$0
RODERICK L STURGEON
DIRECTOR/CFO$0$1,597,472$0$0$0$107,511$0$42,000$0$22,605$0$1,769,588$0$0
DAVID M CHAO
DIRECTOR/PRESIDENT/CEO$1,360,250$0$0$0$9,921$0$42,000$0$1,446$0$1,413,617$0$0$0
ROBERT E KRUMLAUF - TO 72019
DIR/SCIENTIFIC DIR EMERITUS$437,532$0$0$0$193,875$0$42,000$0$21,105$0$694,512$0$0$0
RICHARD W BROWN
DIRECTOR/CHAIR$0$2,516,009$0$0$0$27,489$0$42,000$0$19,830$0$2,605,328$0$0
ALEJANDRO SANCHEZ ALVARADO
DIR/SCIENTIFIC DIR FROM 7/2019$153,849$0$0$0$361$0$16,350$0$401$0$170,961$0$0$0
BRENT KREIDER
CHIEF OPERATING OFFICER$0$607,808$0$0$0$8,844$0$0$0$25,223$0$641,875$0$0
RONALD C CONAWAY
INVESTIGATOR$309,629$0$0$0$3,564$0$42,000$0$1,446$0$356,639$0$0$0
JOAN W CONAWAY
INVESTIGATOR$307,562$0$0$0$3,564$0$42,000$0$19,863$0$372,989$0$0$0
JERRY L WORKMAN
INVESTIGATOR$369,979$0$0$0$3,564$0$42,000$0$12,043$0$427,586$0$0$0
R SCOTT HAWLEY
INVESTIGATOR$368,456$0$0$0$4,191$0$42,000$0$19,908$0$434,555$0$0$0
LINHENG LI
INVESTIGATOR$272,474$0$0$0$3,564$0$40,871$0$1,446$0$318,355$0$0$0

Supplemental Information Detail SupplementalInformationDetail (4 entries)

Form And Line ReferenceFormAndLineReferenceDescExplanationExplanationTxt
PART I, LINE 1A:SIMR HAS A WRITTEN EMPLOYMENT AGREEMENT WITH DAVID M. CHAO, WHICH PROVIDES FOR TAXABLE TERM LIFE BENEFITS AND FOR HIM TO RECEIVE TAX GROSS-UP PAYMENTS SUFFICIENT TO COVER THE TAXES ON THESE BENEFITS.
PART I, LINE 1B:SIMR PROVIDED THE BENEFITS DESCRIBED IN RESPONSE TO LINE 1A PURSUANT TO WRITTEN EMPLOYMENT CONTRACTS THAT WAS APPROVED BY SIMR'S GOVERNING BOARD. SEE RESPONSE TO FORM 990, PART VI, SECTION B, LINE 15, FOR ADDITIONAL PROCESSES RELATED TO DETERMINING EXECUTIVE COMPENSATION.
PART I, LINE 5A:SIMR MADE A PAYMENT OF $188,931 TO ROBERT E. KRUMLAUF, SCIENTIFIC DIRECTOR. THIS PAYMENT REPRESENTS THE PORTION OF THE NET ROYALTIES RECEIVED BY SIMR FOR LICENSED SCIENTIFIC DISCOVERY TECHNOLOGY THAT IS PAYABLE TO ROBERT E. KRUMLAUF, PH.D., FOR HIS PARTICIPATION IN THE DISCOVERY.
PART II, LINES 4 AND 6:ROBERT KRUMLAUF SERVED AS SIMR'S SCIENTIFIC DIRECTOR THROUGH JUNE 30, 2019, AFTER WHICH HE BECAME SCIENTIFIC DIRECTOR EMERITUS. ALEJANDRO SANCHEZ ALVARADO BECAME SIMR'S SCIENTIFIC DIRECTOR ON JULY 1, 2019.

Schedule L IRS990ScheduleL

Bus Tr Involve Interested Prsn BusTrInvolveInterestedPrsnGrp (3 entries)

Relationship DescriptionRelationshipDescriptionTxtTransactionTransactionAmtTransactionTransactionDescSharing Of RevenuesSharingOfRevenuesInd
JULIA ZEITLINGER PHD
SEE PART V$263,391EMPLOYEE OF SIMRfalse
LEANNE WIEDEMANN PHD
SEE PART V$267,756EMPLOYEE OF SIMRfalse
TATJANA PIOTROWSKI PHD
SEE PART V$251,012EMPLOYEE OF SIMRfalse

Supplemental Information Detail SupplementalInformationDetail

FieldValueIRS element (for citing)
Form And Line ReferencePART IV, LINES (1) , (2) & (3):FormAndLineReferenceDesc
ExplanationJULIA ZEITLINGER, PH.D, IS THE SPOUSE OF DAVID M. CHAO, PRESIDENT OF SIMR. MS. ZEITLINGER IS AN ASSOCIATE INVESTIGATOR AT SIMR. MS. ZEITLINGER'S PREVIOUS EMPLOYMENT BEFORE SIMR WAS WITH THE WHITEHEAD INSTITUTE FOR MEDICAL RESEARCH WHERE SHE WAS THE RECIPIENT OF A PREDOCTORAL FELLOWSHIP FROM THE HUMAN FRONTIER SCIENCE PROGRAM. LEANNE WIEDMANN, PH.D, IS THE SPOUSE OF ROBERT KRUMLAUF, SCIENTIFIC DIRECTOR EMERITUS OF SIMR. MS. WIEDEMANN PERFORMS INDEPENDENT SCIENCE RESEARCH AT SIMR AND IS CONCURRENTLY A PROFESSOR AT THE UNIVERSITY OF KANSAS MEDICAL CENTER IN THE DEPARTMENT OF PATHOLOGY AND LABORATORY MEDICINE. TATJANA PIOTROWSKI, PH.D, IS THE SPOUSE OF ALEJANDRO SANCHEZ ALVARADO, DIRECTOR AND SCIENTIFIC DIRECTOR OF SIMR AS OF JULY 2019. MS. PIOTROWSKI IS AN INVESTIGATOR AT SIMR. HER PREVIOUS EMPLOYMENT BEFORE SIMR WAS WITH THE UNIVERSITY OF UTAH'S SCHOOL OF MEDICINE WHERE SHE WAS AN ASSOCIATE PROFESSOR IN THE DEPARTMENT OF NEUROBIOLGOY AND ANATOMY.ExplanationTxt

Schedule M IRS990ScheduleM

FieldValueIRS element (for citing)
Works Of ArtWorksOfArtGrp
Art Historical TreasuresArtHistoricalTreasuresGrp
Art Fractional InterestArtFractionalInterestGrp
Books And PublicationsBooksAndPublicationsGrp
Clothing And Household GoodsClothingAndHouseholdGoodsGrp
Cars And Other VehiclesCarsAndOtherVehiclesGrp
Boats And PlanesBoatsAndPlanesGrp
Intellectual PropertyIntellectualPropertyGrp

Securities Publicly Traded SecuritiesPubliclyTradedGrp

FieldValueIRS element (for citing)
Non Cash CheckboxYes (X)NonCashCheckboxInd
Contribution3ContributionCnt
Noncash Contributions Rpt F990$63,100,000NoncashContributionsRptF990Amt
Method Of Determining RevenuesFAIR MARKET VALUEMethodOfDeterminingRevenuesTxt
FieldValueIRS element (for citing)
Securities Closely Held StockSecuritiesCloselyHeldStockGrp
Secur Prtnrshp Trust IntrstsSecurPrtnrshpTrustIntrstsGrp
Securities MiscellaneousSecuritiesMiscellaneousGrp
Qualified Contrib Hist StructQualifiedContribHistStructGrp
Qualified Contrib OtherQualifiedContribOtherGrp
Real Estate ResidentialRealEstateResidentialGrp
Real Estate CommercialRealEstateCommercialGrp
Real Estate OtherRealEstateOtherGrp
CollectiblesCollectiblesGrp
Food InventoryFoodInventoryGrp
Drugs And Medical SuppliesDrugsAndMedicalSuppliesGrp
TaxidermyTaxidermyGrp
Historical ArtifactsHistoricalArtifactsGrp
Scientific SpecimensScientificSpecimensGrp
Archaeological ArtifactsArchaeologicalArtifactsGrp
Any Property That Must Be HeldfalseAnyPropertyThatMustBeHeldInd
Review Process Unusual NC GiftsYes (true)ReviewProcessUnusualNCGiftsInd
Third Parties UsedfalseThirdPartiesUsedInd

Supplemental Information Detail SupplementalInformationDetail

FieldValueIRS element (for citing)
Form And Line ReferencePART I, COLUMN B:FormAndLineReferenceDesc
ExplanationTHE AMOUNTS SHOWN IN PART I, COLUMN (B) FOR "NUMBER OF CONTRIBUTIONS" REPRESENTS THE TOTAL NUMBER OF CONTRIBUTIONS AND NOT NECESSARILY THE TOTAL NUMBER OF ITEMS CONTRIBUTED.ExplanationTxt

Schedule O IRS990ScheduleO

Supplemental Information Detail SupplementalInformationDetail (7 entries)

Form And Line ReferenceFormAndLineReferenceDescExplanationExplanationTxt
PART III, LINE 1:THE STOWERS INSTITUTE FOR MEDICAL RESEARCH ("SIMR") PERFORMS MEDICAL RESEARCH IN THE PUBLIC INTEREST WITH THE GOAL OF EXPANDING THE UNDERSTANDING OF FUNDAMENTAL PROCESSES IN LIVING CELLS AND IMPROVING LIFE'S QUALITY THROUGH INNOVATIVE APPROACHES TO THE CAUSES, TREATMENT, AND PREVENTION OF DISEASE. PART III, LINE 4: SIMR'S ACCOMPLISHMENTS ARE DESCRIBED AT THE END OF SCHEDULE O. PART VI, LINE 2: VIRGINIA G. STOWERS, JONATHAN THOMAS, RICHARD W. BROWN, DAVID A. WELTE, DAVID M. CHAO, ALBERZINE FREEMAN, AND ALEJANDRO SANCHEZ ALVARADO, ALL DIRECTORS OF SIMR, HAVE A BUSINESS RELATIONSHIP. JONATHAN THOMAS, RICHARD W. BROWN, DAVID A. WELTE, DAVID M. CHAO, RODERICK L. STURGEON, AND ALBERZINE FREEMAN, DIRECTORS OF SIMR, AND BRENT KREIDER, OFFICER OF SIMR, HAVE A BUSINESS RELATIONSHIP. DAVID A. WELTE, RICHARD W. BROWN, AND RODERICK L. STURGEON, DIRECTORS OF SIMR, AND BRENT KREIDER, OFFICER OF SIMR, HAVE A BUSINESS RELATIONSHIP. PART VI, LINE 11B: THE DATA AND INFORMATION NECESSARY TO PREPARE SIMR'S FORM 990 WAS COMPILED BY SIMR'S ACCOUNTING DEPARTMENT AND THEN REVIEWED BY THE INSTITUTE'S S TAX ATTORNEY AT BRYAN CAVE LEIGHTON PAISNER, LLP. PRICEWATERHOUSECOOPERS ("PWC"), THE INSTITUTE'S EXTERNAL TAX PREPARERS, USED THIS INFORMATION TO PREPARE THE FORM 990. THE COMPLETED FORM 990, INCLUDING REQUIRED SCHEDULES, IS REVIEWED BY THE OFFICERS OF SIMR BEFORE IT IS FILED WITH THE IRS. AFTER THE PREPARATION AND REVIEW PROCESS DESCRIBED ABOVE, THE FORM 990, INCLUDING REQUIRED SCHEDULES, IS PROVIDED TO EACH VOTING MEMBER OF THE ORGANIZATION'S BOARD BEFORE IT IS FILED WITH THE IRS. PART VI, LINE 12C: SIMR HAS ADOPTED A "CONFLICTS OF INTEREST AND DIRECTOR INDEPENDENCE POLICY". EACH DIRECTOR, OFFICER, AND ALL OTHER PERSONS IN A POSITION TO EXERCISE SUBSTANTIAL INFLUENCE OVER DECISIONS OF SIMR ARE REQUIRED TO ANNUALLY COMPLETE AND SIGN A DISCLOSURE STATEMENT THAT IS PART OF THE POLICY. A COVERED PERSON MUST ALSO DISCLOSE THE EXISTENCE OF A POTENTIAL CONFLICT AND ALL MATERIAL FACTS TO THE GOVERNING BOARD AS SOON AS THE PERSON HAS KNOWLEDGE THAT A POTENTIAL CONFLICT MIGHT EXIST. SIMR CONDUCTS PERIODIC AND ADHOC REVIEWS OF TRANSACTIONS AND AGREEMENTS TO ENSURE THAT IT ENGAGES ONLY IN ACTIVITIES THAT ARE CONSISTENT WITH ITS TAX-EXEMPT PURPOSE. FORM 990, PART VI, LINE 15A: THE COMPENSATION FOR DAVID CHAO, THE PRESIDENT AND CEO OF SIMR, WAS ESTABLISHED PURSUANT TO THE PROCEDURES OF TREAS. REG. SECTION 53.4958- 6, INCLUDING (1) REVIEW AND APPROVAL BY SIMR'S COMPENSATION COMMITTEE COMPRISED OF INDEPENDENT PERSONS, (2) RELYING ON COMPARABILITY DATA, INCLUDING DATA PREPARED BY A NATIONALLY KNOWN COMPENSATION CONSULTANT REGARDING COMPARABLE SALARY AND BENEFITS FOR SIMILARLY QUALIFIED PERSONS IN FUNCTIONALLY COMPARABLE POSITIONS AT SIMILARLY SITUATED ORGANIZATIONS, AND (3) CONTEMPORANEOUS DOCUMENTATION AND RECORD KEEPING OF THE DELIBERATION AND DECISIONS REGARDING THE COMPENSATION ARRANGEMENT. THIS PROCESS WAS LAST UNDERTAKEN IN 2019. PART VI, LINE 19: SIMR'S GOVERNING DOCUMENTS, CONFLICT OF INTEREST POLICY, AND FINANCIAL STATEMENTS ARE AVAILABLE UPON REQUEST. PART VII, SECTION A, COLUMN B: DAVID M. CHAO, OFFICER OF SIMR, AND R. SCOTT HAWLEY, EMPLOYEE OF SIMR, ALSO PERFORM SUPPORT SERVICES FOR ONE OR MORE OF THE RELATED ORGANIZATIONS DISCLOSED IN SCHEDULE R. THESE SERVICES ARE PERFORMED IN THEIR ROLE AS SIMR EMPLOYEES AND SIMR IS REIMBURSED BY THE RELATED ORGANIZATIONS. PART VII, SECTION B: SIMR RECEIVES INVESTMENT MANAGEMENT SERVICES FROM AMERICAN CENTURY INVESTMENTS ("ACI"). ACI IS A WHOLLY OWNED SUBSIDIARY OF AMERICAN CENTURY COMPANIES, INC. ("ACCI"). IN SELECTING ACI TO MANAGE ITS LIQUID INVESTMENTS, SIMR NOT ONLY CHOSE A HIGH QUALITY MUTUAL FUND COMPANY WITH AN OUTSTANDING TRACK RECORD, BUT ALSO PLACED ITS LIQUID INVESTMENTS IN A COMPANY IN WHICH IT OWNS STOCK AND RECEIVES DIVIDENDS. SIMR PAYS ACI THE SAME ADMINISTRATIVE FEES FOR THESE SERVICES AS ANY ARMS-LENGTH INVESTOR.THOSE INVESTMENT FEES FOR A SHARED INVESTMENT POOL ARE PAID BY ITS SUPPORTING ORGANIZATION, STOWERS RESOURCE MANAGEMENT. PART XI, LINE 9: OTHER CHANGES IN NET ASSETS INCLUDE THE FOLLOWING: CHANGE IN ANNUITY RECEIVABLE, NET ($234,502)
PART III, LINE 4A2019 PROGRAM SERVICE ACCOMPLISHMENTS THE STOWERS INSTITUTE FOR MEDICAL RESEARCH ("SIMR") IS A PRIVATE, NONPROFIT MEDICAL RESEARCH ORGANIZATION. SIMR WAS FOUNDED IN 1994 BY JIM AND VIRGINIA STOWERS, WHO EACH SURVIVED A BOUT WITH CANCER AND SUBSEQUENTLY DEDICATED THEIR FORTUNE TO SUPPORTING BASIC RESEARCH IN CELL AND MOLECULAR BIOLOGY THAT WILL PROVIDE LONG-TERM SOLUTIONS TO HUMAN DISEASES. SIMR CONDUCTS BASIC BIOMEDICAL RESEARCH IN THE PUBLIC INTEREST THAT WILL ULTIMATELY PROVIDE A GREATER UNDERSTANDING OF THE GENES AND PROTEINS THAT CONTROL HOW CELLS IN OUR BODIES MULTIPLY, FORM TISSUES, AND DIE. STUDYING THE BASIC BIOLOGY OF CELLS ENABLES SCIENTISTS TO DISCOVER HOW GENES CAUSE MANY DISEASES, INCLUDING CANCER, BIRTH DEFECTS, AND DEMENTIA. HISTORY HAS SHOWN THAT BASIC MEDICAL RESEARCH IS OFTEN A KEY FIRST STEP IN THE DEVELOPMENT OF NEW TREATMENTS, CURES, AND PREVENTIONS FOR MANY HUMAN DISEASES. 2019 NOTABLE RESEARCH RESULTS IN 2019, SIMR RESEARCH TEAMS MADE DISCOVERIES MERITING PUBLICATION IN LEADING PEER-REVIEWED SCIENTIFIC JOURNALS - 74 ORIGINAL RESEARCH PAPERS IN ALL. SIMR RESEARCH TEAMS ALSO PRODUCED 34 OTHER PUBLICATIONS INCLUDING REVIEWS, COMMENTARIES, BOOK CHAPTERS, AND BOOKS. SOME OF THE HIGHLIGHTS AMONG THESE PAPERS AND OTHER ADVANCES INVOLVING STOWERS RESEARCH INCLUDE THE FOLLOWING: THE KRUMLAUF LAB HELPED LAY THE GROUNDWORK FOR A NEW APPROACH TO TREATING OSTEOPOROSIS WITH AN UNEXPECTED DISCOVERY MADE NEARLY TWO DECADES AGO. AFTER UNCOVERING A MECHANISM THAT CONTROLS BONE GROWTH, THEIR WORK WAS PATENTED AND THE INTELLECTUAL PROPERTY LICENSED TO AMGEN IN 2005. AMGEN USED THAT FINDING AS WELL AS OTHERS' RESEARCH ABOUT BONE GROWTH TO DEVELOP A NEW DRUG, ROMOSOZUMAB. TWO PHASE 3 CLINICAL TRIALS SHOWED A SIGNIFICANT REDUCTION OF FRACTURES. THE DRUG ALSO INCREASED BONE DENSITY IN THE SPINES OF STUDY PARTICIPANTS BY AROUND 15%. ROMOSOZUMAB, THE FIRST NEW DRUG AIDED BY RESEARCH FROM SIMR, WAS APPROVED BY THE US FOOD AND DRUG ADMINISTRATION IN JANUARY 2019. THE LI LAB PUBLISHED A STUDY DESCRIBING HOW BLOOD-FORMING ADULT STEM CELLS REPOPULATE AFTER CHEMOTHERAPY. THESE CELLS, CALLED "RESERVE" HEMATOPOIETIC STEM CELLS, RESIDE IN BONE MARROW. THEY ARE RESPONSIBLE FOR REGENERATING THE BODY'S BLOOD SUPPLY, REPOPULATING AFTER CHEMOTHERAPY OR INJURY DEPLETES THEIR NUMBERS. THE FINDINGS MAY OPEN NEW AVENUES FOR TREATING BLOOD DISEASES LIKE LEUKEMIA AND AUTOIMMUNE DISORDERS. THE STUDY WAS PUBLISHED ONLINE JANUARY 15, 2019, IN CELL REPORTS. THE WASHBURN LAB CREATED A TOPOLOGICAL SCORING (TOPS) ALGORITHM, WHICH ALLOWS SCIENTISTS TO LOOK AT BIG SETS OF DATA IN NEW WAYS. THIS HELPS SCIENTISTS UNCOVER MORE DETAILS ABOUT HOW PROTEINS INTERACT AND UNDERSTAND HOW CERTAIN ACTIVITIES ON THE CELLULAR LEVEL HAPPEN. THE REPORT WAS PUBLISHED IN THE MARCH 8, 2019, ISSUE OF NATURE COMMUNICATIONS. THE BAZZINI LAB SHOWED THAT IN HUMAN CELL LINES, RIBOSOMES PLAY AN ACTIVE ROLE IN REGULATING MRNAS - THE MESSAGES THAT RIBOSOMES READ TO MAKE PROTEINS. THE STUDY ALSO PROVIDES EVIDENCE FOR ANOTHER LAYER OF INFORMATION WITHIN THE MESSAGES THAT CAN AFFECT MRNA LEVELS AND STABILITY. UNDERSTANDING THE REGULATORY FUNCTION OF RIBOSOMES IN MODULATING GENE EXPRESSION IN HUMAN CELLS CAN PROVIDE INSIGHT ABOUT CAUSES OF GENE MISREGULATION, WHICH CAN SOMETIMES LEAD TO HUMAN DISEASES. THE FINDINGS WERE PUBLISHED ONLINE APRIL 23, 2019, IN ELIFE. THE GERTON LAB UNCOVERED AN ANSWER TO A CENTURIES-OLD QUESTION OF HOW CONNECTIONS BETWEEN PARTICULAR HUMAN CHROMOSOMES MIGHT BE BUILT. THESE INTER-CHROMOSOMAL CONNECTIONS ARE COMPOSED OF RIBOSOMAL DNA WITH A SHARED SEQUENCE. THE FINDINGS SUGGEST THAT THE CONNECTIONS ARE CONTROLLED BY THE PROXIMITY OF THE CHROMOSOMES IN THREE-DIMENSIONAL SPACE AND THEIR TRANSCRIPTION, WHICH TOGETHER ALLOW CHROMOSOMES TO BUMP INTO EACH OTHER AND BECOME INTERLOCKED. THE FINDINGS COULD PROVIDE CLUES ABOUT THE ORIGINS OF CHROMOSOMAL FUSIONS ASSOCIATED WITH INFERTILITY AND DEVELOPMENTAL DISORDERS IN HUMANS. THE ARTICLE WAS PUBLISHED JULY 23, 2019, IN THE JOURNAL OF CELL BIOLOGY. THE GIBSON LAB PUBLISHED RESEARCH HIGHLIGHTING THE IMPORTANCE OF UNIFORM CELL SIZE IN MAINTAINING THE ARCHITECTURE OF EPITHELIAL SHEETS. ABNORMALLY SMALL EPITHELIAL CELLS CAN DISSOCIATE FROM EACH OTHER AND DISPERSE AMONG NORMAL CELLS. A SERIES OF EXPERIMENTS SHOWED THAT ABNORMAL SMALL-CELL DISPERSAL RESULTS FROM GEOMETRIC EFFECTS OF CELL SIZE VARIATION ON EPITHELIAL PACKING. THESE FINDINGS MAY FURTHER THE UNDERSTANDING OF HUMAN DISEASE PROGRESSION. THE STUDY WAS PUBLISHED ONLINE SEPTEMBER 5, 2019, IN DEVELOPMENTAL CELL. THE HAWLEY LAB DISCOVERED MORE DETAILS ABOUT HOW THE SYNAPTONEMAL COMPLEX IN MEIOSIS PERFORMS ITS JOB. THIS LARGE PROTEIN COMPLEX IS A CRITICAL PLAYER IN THE SEGREGATION OF CHROMOSOMES DURING MEIOSIS. EXPERIMENTS INDICATED THAT THE X CHROMOSOME OF THE FRUIT FLY IS SENSITIVE TO DEFECTS IN THE STRUCTURE OF THE SYNAPTONEMAL COMPLEX, WITH EFFECTS VARYING DEPENDING PARTLY ON THE STAGE OF MEIOSIS. THE RESEARCH MAY HELP FURTHER UNDERSTANDING OF THE CAUSES OF HUMAN MISCARRIAGE. THE WORK WAS PUBLISHED ONLINE SEPTEMBER 30, 2019, IN THE PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES. THE WASHBURN LAB UNCOVERED NEW DETAILS ABOUT SEVERAL PROTEINS IMPLICATED IN CANCER. THE RESEARCH FOCUSED ON THE SMAD4, A TRANSCRIPTION FACTOR THAT NORMALLY SUPPRESSES TUMOR GROWTH, AND A PROTEIN CALLED BRK THAT BINDS TO SMAD4 AND LEADS TO ITS BREAKDOWN. THEIR WORK EXAMINED THE PROTEINS IN HUMAN CELL LINES INCLUDING BREAST CELL CANCER TYPES AND SUGGESTED THAT TREATMENTS TARGETING BRK, WHICH IS PRESENT IN MORE THAN 85 PERCENT OF BREAST CANCER TUMORS, COULD HELP REDUCE OR STOP TUMOR GROWTH. THE STUDY WAS PUBLISHED ONLINE OCTOBER 23, 2019, IN SCIENCE ADVANCES. COMPREHENSIVE LISTS OF 2019 ORIGINAL RESEARCH PAPERS, REVIEWS, COMMENTARIES, CHAPTERS, AND BOOKS ORIGINAL RESEARCH PAPERS
1. EFFICIENT DEPLETION OF RIBOSOMAL RNA FOR SEQUENCING INPLANARIANS. KIM IV,ROSS EJ, DIETRICH S, DORING K, SNCHEZ ALVARADO A, KUHN CD. BMC GENOMICS.2019;20:909. DOI: 10.1186/S12864-019-6292-Y. 2. BRK PHOSPHORYLATES SMAD4 FOR PROTEASOMAL DEGRADATION AND INHIBITS TUMOR SUPPRESSOR FRK TO CONTROL SNAIL, SLUG AND METASTATIC POTENTIAL. MIAH S, BANKS CAS,OGUNBOLUDE Y, BAGU ET, BERG JM, SARAF A, TETTEY TT, HATTEM G, DAYEBGADOH G, KEMPF CG, SARDIU M, NAPPER S, FLORENS L, LUKONG KE, WASHBURN MP. SCI ADV.2019;5:EAAW3113. DOI: 3110.1126/SCIADV.AAW3113. 3. PLANARIANS RECRUIT PIRNAS FOR MRNA TURNOVER IN ADULT STEM CELLS. KIM IV, DUNCAN EM, ROSS EJ, GORBOVYTSKA V, NOWOTARSKI SH, ELLIOTT SA, SNCHEZ ALVARADO A, KUHN CD.GENES DEV. 2019;33:1575-1590. 4. AN ADULT BRAIN ATLAS REVEALS BROAD NEUROANATOMICAL CHANGES IN INDEPENDENTLY EVOLVED POPULATIONS OF MEXICAN CAVEFISH. LOOMIS C, PEUSS R, JAGGARD JB, WANG Y,MCKINNEY S, RAFTOPOULOS A, RAFTOPOULOS S, WHU D, GREEN MR, MCGAUGH SE, ROHNER NE, KEENE AC, DUBOUE ER. FRONT NEUROANAT. 2019;13:88. DOI: 10.3389/FNANA.2019.00088. 5. X CHROMOSOME AND AUTOSOMAL RECOMBINATION ARE DIFFERENTIALLY SENSITIVE TO DISRUPTIONS IN SC MAINTENANCE. BILLMYRE KK, CAHOON CK, HEENAN GM, WESLEY ER, YU Z,UNRUH JR, TAKEO S, HAWLEY RS. PROC NATL ACAD SCI U S A. 2019;116:21641-21650. 6. AN ATLAS OF TRANSCRIPTION FACTORS EXPRESSED IN MALE PUPAL TERMINALIA OF DROSOPHILA MELANOGASTER. VINCENT BJ, RICE GR, WONG GM, GLASSFORD WJ, DOWNS KI, SHASTAY JL, CHARLES-OBI K, NATARAJAN M, GOGOL M, ZEITLINGER J, REBEIZ M. G3(BETHESDA). 2019. DOI: 10.1534/G3.119.400788. 7. DEFINING THE EXPRESSION OF PIRNA AND TRANSPOSABLE ELEMENTS IN DROSOPHILA OVARIAN GERMLINE STEM CELLS AND SOMATIC SUPPORT CELLS. STORY B, MA X, ISHIHARA K, LI H, HALL K, PEAK A, ANOJA P, PARK J, HAUG J, BLANCHETTE M, XIE T. LIFE SCI ALLIANCE.2019;2:E201800211. DOI: 10.26508/LSA.XXX-XX-XXXX. 8. EVOLUTIONARY ORIGIN AND NOMENCLATURE OF VERTEBRATE WNT11-FAMILY GENES.POSTLETHWAIT JH, NAVAJAS ACEDO J, PIOTROWSKI T. ZEBRAFISH. 2019;16:469-476. 9. PERTURBED CRANIAL NEURAL CREST CELL DEVELOPMENT IN ASSOCIATION WITH REDUCED SONIC HEDGEHOG SIGNALING UNDERLIES THE PATHOGENESIS OF RETINOIC-ACID-INDUCED CLEFT PALATE. WANG Q, KUROSAKA H, KIKUCHI M, NAKAYA A, TRAINOR PA, YAMASHIRO T. DIS MODEL MECH. 2019;12. 10. EXPERIMENTAL EVOLUTION OF IMMUNOLOGICAL SPECIFICITY. FERRO K, PEUSS R, YANG W,ROSENSTIEL P, SCHULENBURG H, KURTZ J. [PUBLISHED AHEAD OF PRINT SEPTEMBER 23 2019].PNAS. 2019. 11. PROTRUSION MEMBRANE PEARLING EMERGES DURING THREE-DIMENSIONAL CELL DIVISION.CABALLERO D, MENDES PINTO I, RUBINSTEIN B, SAMITIER J. PHYS BIOL. 2019. 12. DNA-DEPENDENT PROTEIN KINASE CATALYTIC SUBUNIT (DNA-PKCS) CONTRIBUTES TO INCORPORATION OF HISTONE VARIANT H2A.Z INTO NUCLEOSOMES. WANG LY, HE YX, LI M,DING J, SUI Y, CONAWAY JW, CONAWAY RC, WANG F, JIN J, CAI Y. PROTEIN CELL. 2019;10:694-699. 13. IDENTIFICATION OF A NUCLEAR LOCALIZATION SIGNAL AND IMPORTIN BETA MEMBERS MEDIATING NUAK1 NUCLEAR IMPORT INHIBITED BY OXIDATIVE STRESS. PALMA M, RIFFO EN,SUGANUMA T, WASHBURN MP, WORKMAN JL, PINCHEIRA R, CASTRO AF. J CELL BIOCHEM.2019;120:16088-16107. 14. CELL-SIZE PLEOMORPHISM DRIVES ABERRANT CLONE DISPERSAL IN PROLIFERATING EPITHELIA. RAMANATHAN SP, KRAJNC M, GIBSON MC. DEV CELL. 2019;51:49-61 E44. 15. PCP AND WNT PATHWAY COMPONENTS ACT IN PARALLEL DURING ZEBRAFISH MECHANOSENSORY HAIR CELL ORIENTATION. NAVAJAS ACEDO J, VOAS MG, ALEXANDER R, WOOLLEY T, UNRUH JR, LI H, MOENS C, PIOTROWSKI T. NAT COMMUN. 2019;10:3993. DOI:3910.1038/S41467-41019-12005-Y. 16. BIOCHEMICAL REDUCTION OF THE TOPOLOGY OF THE DIVERSE WDR76 PROTEIN INTERACTOME.DAYEBGADOH G, SARDIU ME, FLORENS L, WASHBURN MP. J PROTEOME RES. 2019;18:3479-3491. 17. GENERATING TOPOLOGICAL PROTEIN INTERACTION SCORES AND DATA VISUALIZATION WITH TOPS. SARDIU M, FLORENS L, WASHBURN MP. [PUBLISHED AHEAD OF PRINT SEPTEMBER 3 2019]. METHODS. 2019. 18. CLUSTERMAP: COMPARE MULTIPLE SINGLE CELL RNA-SEQ DATASETS ACROSS DIFFERENT EXPERIMENTAL CONDITIONS. GAO X, HU D, GOGOL M, LI H. BIOINFORMATICS. 2019;35:3038-3045. 19. AN ATLAS OF ANTERIOR HOX GENE EXPRESSION IN THE EMBRYONIC SEA LAMPREY HEAD: HOXCODE EVOLUTION IN VERTEBRATES. PARKER HJ, BRONNER ME, KRUMLAUF R. DEV BIOL.2019;453:19-33. 20. STABLE TRANSGENESIS IN ASTYANAX MEXICANUS USING THE TOL2 TRANSPOSASE SYSTEM.STAHL BA, PEUSS R, MCDOLE B, KENZIOR A, JAGGARD JB, GAUDENZ K, KRISHNAN J, MCGAUGH SE, DUBOUE ER, KEENE AC, ROHNER N. DEV DYN. 2019;248:679-687. 21. THE E3 UBIQUITIN LIGASE SPOP CONTROLS RESOLUTION OF SYSTEMIC INFLAMMATION BY TRIGGERING MYD88 DEGRADATION. GUILLAMOT M, OUAZIA D, DOLGALEV I, YEUNG ST,KOURTIS N, DAI Y, CORRIGAN K, ZEA-REDONDO L, SARAF A, FLORENS L, WASHBURN MP,TIKHONOVA AN, MALUMBRES M, GONG Y, TSIRIGOS A, PARK C, BARBIERI C, KHANNA KM,BUSINO L, AIFANTIS I. NAT IMMUNOL. 2019;20:1196-1207. 22. A CONSERVED REGULATORY PROGRAM INITIATES LATERAL PLATE MESODERM EMERGENCE ACROSS CHORDATES. PRUMMEL KD, HESS C, NIEUWENHUIZE S, PARKER HJ, ROGERS KW,KOZMIKOVA I, RACIOPPI C, C. BE, CZARKWIANI A, KNAPP D, BURGER S, CHIAVACCI E, SHAH G,BURGER A, HUISKEN J, YUN M, CHRISTIAEN L, KOZMIK Z, CHRISTIAEN L, MULLER P, BRONNER M,KRUMLAUF R, MOSIMANN C. NAT COMMUN. 2019;10:E3857. DOI: 3810.1038/S41467-41019-11561-41467. 23. MEASURING SIMILARITY BETWEEN GENE INTERACTION PROFILES. BARIDO-SOTTANI J,CHAPMAN SD, KOSMAN E, MUSHEGIAN AR. BMC BIOINFORMATICS. 2019;20:435. DOI:410.1186/S12859-12019-13024-X. 24. COMPARISON OF BLEACHING PROTOCOLS UTILIZING HEMATOXYLIN AND EOSIN STAIN ANDIMMUNOHISTOCHEMICAL PROLIFERATION MARKER MCM3 IN PIGMENTED MELANOMAS. JORDAN T, WILLIAMS D, CRISWELL S, WANG Y. [PUBLISHED AHEAD OF PRINT AUGUST 17 2019].J HISTOTECHNOL. 2019:1-6. 25. ALKALINE PHOSPHATASE-BASED CHROMOGENIC AND FLUORESCENCE DETECTION METHOD FOR BASESCOPE IN SITU HYBRIDIZATION. WANG Y, XU W, MADDERA L, TSUCHIYA D, THOMAS N, YU CR, PARMELY T. [PUBLISHED AUGUST 17 2019]. J HISTOTECHNOL. 2019:1-9. 26. WNT AND TGF-? COORDINATE GROWTH AND PATTERNING TO REGULATE SIZE-DEPENDENT BEHAVIOR. ARNOLD CP, BENHAM-PYLE BW, LANGE JJ, WOOD CJ, SNCHEZ ALVARADO A.NATURE. 2019;572:655-659. 27. DETECTING AND CHARACTERIZING PROTEIN SELF-ASSEMBLY IN VIVO BY FLOW CYTOMETRY.VENKATESAN S, KANDOLA TS, RODRIGUEZ-GAMA A, BOX A, HALFMANN R. J VIS EXP.2019;149:E59577. DOI: 59510.53791/59577. 28. FILLING IN THE PHYLOGENETIC GAPS: INDUCTION, MIGRATION AND DIFFERENTIATION OF NEURAL CREST CELLS IN A SQUAMATE REPTILE, THE VEILED CHAMELEON (CHAMAELEOCALYPTRATUS). DIAZ RE, JR., SHYLO NA, ROELLIG D, BRONNER M, TRAINOR PA. DEV DYN.2019;248:709-727. 29. THE TRANSCRIPTOME OF THE VEILED CHAMELEON (CHAMAELEO CALYPTRATUS): A RESOURCE FOR STUDYING THE EVOLUTION AND DEVELOPMENT OF VERTEBRATES. PINTO BJ, CARD DC, CASTOE TA, DIAZ RE, JR., NIELSEN SV, TRAINOR PA, GAMBLE T. DEV DYN. 2019;248:702-708. 30. RUNX PROTEINS DESENSITIZE MULTIPLE MYELOMA TO LENALIDOMIDE VIA PROTECTING IKZFS FROM DEGRADATION. ZHOU N, GUTIERREZ-UZQUIZA A, ZHENG XY, CHANG R, VOGL DT,GARFALL AL, BERNABEI L, SARAF A, FLORENS L, WASHBURN MP, ILLENDULA A, BUSHWELLER JH,BUSINO L. LEUKEMIA. 2019;33:2006-2021. 31. ATAXIN-7 AND NON-STOP COORDINATE SCAR PROTEIN LEVELS, SUBCELLULAR LOCALIZATION,AND ACTIN CYTOSKELETON ORGANIZATION. CLOUD V, THAPA A, MORALES-SOSA P, MILLER T,MILLER SA, HOLSAPPLE D, GERHART P, MOMTAHAN E, JACK JL, LEIVA E, RAPP SR, SHELTON LG,PIERCE RA, MARTIN-BROWN S, FLORENS L, WASHBURN MP, MOHAN RD. ELIFE. 2019;8. DOI:10.7554/ELIFE.49677. 32. STRUCTURES OF AUTOINHIBITED AND POLYMERIZED FORMS OF CARD9 REVEAL MECHANISMS OF CARD9 AND CARD11 ACTIVATION. HOLLIDAY MJ, WITT A, RODRIGUEZ GAMA A, WALTERS BT,ARTHUR CP, HALFMANN R, ROHOU A, DUEBER EC, FAIRBROTHER WJ. NAT COMMUN.2019;10:3070. DOI: 10.1038/S41467-019-10953-Z. 33. COMPREHENSIVE SINGLE-CELL TRANSCRIPTOME LINEAGES OF A PROTO-VERTEBRATE. CAO C,LEMAIRE LA, WANG W, YOON PH, CHOI YA, PARSONS LR, MATESE JC, WANG W, LEVINE M,CHEN K. NATURE. 2019;571:349-354.
34. AMYLOID-LIKE ASSEMBLY ACTIVATES A PHOSPHATASE IN THE DEVELOPINGDROSOPHILA EMBRYO. NIL Z, MILLAN RH, GERBICH T, LEAL P, YU Z, SARAF A, SARDIU M, LANGE JJ, YI K, UNRUH J, SLAUGHTER B, SI K. CELL. 2019;178:1403-1420 E1421. 35. SUPER-RESOLUTION MICROSCOPY REVEALS LINKAGES BETWEEN RIBOSOMAL DNA ON HETEROLOGOUS CHROMOSOMES. POTAPOVA TA, UNRUH JR, YU Z, RANCATI G, LI H, STAMPFER MR, GERTON JL. J CELL BIOL. 2019;218:2492-2513. 36. SIGNATURES OF DIVERGENCE, INVASIVENESS AND TERRESTRALIZATION REVEALED BY FOUR APPLE SNAIL GENOMES. SUN J, MU H, IP JCH, LI R, XU T, ACCORSI A, SNCHEZ ALVARADO A, ROSS E, LAN Y, SUN Y, CASTRO-VAZQUEZ A, VEGA IA, HERAS H, ITUARTE S, VAN BOCXLAER B, HAYES KA, COWIE RH, ZHAO Z, ZHANG Y, QIAN PY, QIU JW. MOL BIOL EVOL. 2019;36:1507-1520. 37. P53 AND B-CATENIN EXPRESSION PREDICT POORER PROGNOSIS IN PATIENTS WITH ANAPLASTIC LARGE-CELL LYMPHOMA. RICHARDSON AI, YIN CC, CUI W, LI N, MEDEIROS LJ, LI L, ZHANG D. CLIN LYMPHOMA MYELOMA LEUK. 2019;19:E385-E392. DOI: 310.1016/J.CLML.2019.1003.1030. 38. THE STOICHIOMETRY OF THE OUTER KINETOCHORE IS MODULATED BY MICROTUBULE-PROXIMAL REGULATORY FACTORS. DHATCHINAMOORTHY K, UNRUH JR, LANGE JJ, LEVY M, SLAUGHTER BD, GERTON JL. J CELL BIOL. 2019;218:2124-2135. 39. THE EXOCYST FUNCTIONS IN NICHE CELLS TO PROMOTE GERMLINE STEM CELL DIFFERENTIATION BY DIRECTLY CONTROLLING EGFR MEMBRANE TRAFFICKING. MAO Y, TU R, HUANG Y, MAO D, YANG Z, LAU PK, WANG J, NI J, GUO Y, XIE T. DEVELOPMENT. 2019;146:DEV174615 DOI: 174610.171242/DEV.174615. 40. A ROLE FOR FACT IN RNA POLYMERASE II PROMOTER-PROXIMAL PAUSING. TETTEY TT, GAO X, SHAO W, STORY BA, CHITSAZAN AD, GLASER RL, SEIDEL CW, CONAWAY RC, ZEITLINGER J, BLANCHETTE M, CONAWAY JW. CELL REP. 2019;27:3770-3779 E7. 41. JUNCTIONAL TUMOR SUPPRESSORS INTERACT WITH 14-3-3 PROTEINS TO CONTROL PLANAR SPINDLE ALIGNMENT. NAKAJIMA YI, LEE ZT, MCKINNEY SA, SWANSON SK, FLORENS L, GIBSON MC. J CELL BIOL. 2019;218:1824-1838. 42. STRUCTURE AND FUNCTION OF SPC42 COILED-COILS IN YEAST CENTROSOME ASSEMBLY AND DUPLICATION. DRENNAN AC, KRISHNA S, SEEGER MA, ANDREAS MP, GARDNER JM, SETHER EKR, JASPERSEN SL, RAYMENT I. MOL BIOL CELL. 2019;30:1505-1522. 43. KILLER MEIOTIC DRIVE AND DYNAMIC EVOLUTION OF THE WTF GENE FAMILY. EICKBUSH MT, YOUNG JM, ZANDERS SE. MOL BIOL EVOL. 2019;36:1201-1214. 44. GAMETE COLLECTION AND IN VITRO FERTILIZATION OF ASTYANAX MEXICANUS. PEUSS R, ZAKIBE Z, KRISHNAN J, MERRYMAN MS, BAUMANN DP, ROHNER N. J VIS EXP. 2019. DOI: 10.3791/59334. 45. DOWNREGULATION OF FGF SIGNALING BY SPRY4 OVEREXPRESSION LEADS TO SHAPE IMPAIRMENT, ENAMEL IRREGULARITIES, AND DELAYED SIGNALING CENTER FORMATION IN THE MOUSE MOLAR. MARANGONI P, CHARLES C, AHN Y, SEIDEL K, JHEON A, GANSS B, KRUMLAUF R, VIRIOT L, KLEIN OD. JBMR PLUS. 2019;3:E10205. DOI: 10210.11002/JBM10204.10205. 46. THE E3 UBIQUITIN LIGASE SINA REGULATES THE ASSEMBLY AND DISASSEMBLY OF THE SYNAPTONEMAL COMPLEX IN DROSOPHILA FEMALES. HUGHES SE, HEMENWAY E, GUO F, YI K, YU Z, HAWLEY RS. PLOS GENET. 2019;15:E1008161. DOI: 10.1371/JOURNAL.PGEN.1008161. 47. ARTIFICIAL RNA POLYMERASE II ELONGATION COMPLEXES FOR DISSECTING CO-TRANSCRIPTIONAL RNA PROCESSING EVENTS. NOE GONZALEZ M, CONAWAY JW, CONAWAY RC. J VIS EXP. 2019;147: DOI: 10.3791/59497. 48. HYPO-OSMOTIC-LIKE STRESS UNDERLIES GENERAL CELLULAR DEFECTS OF ANEUPLOIDY. TSAI HJ, NELLIAT AR, CHOUDHURY MI, KUCHARAVY A, BRADFORD WD, COOK ME, KIM J, MAIR DB, SUN SX, SCHATZ MC, LI R. NATURE. 2019;570:117-121. 49. YEAST CENTROSOME COMPONENTS FORM A NONCANONICAL LINC COMPLEX AT THE NUCLEAR ENVELOPE INSERTION SITE. CHEN J, GARDNER JM, YU Z, SMITH SE, MCKINNEY S, SLAUGHTER BD, UNRUH JR, JASPERSEN SL. J CELL BIOL. 2019;218:1478-1490. 50. DOPAMINE RECEPTOR ANTAGONISTS AS POTENTIAL THERAPEUTIC AGENTS FOR ADPKD. PAUL P, RAMACHANDRAN S, XIA S, UNRUH JR, CONKRIGHT-FINCHAM J, LI R. PLOS ONE. 2019;14:E0216220. DOI: 10.1371/JOURNAL.PONE.0216220. 51. REPORTER-CHIP-NEXUS REVEALS STRONG CONTRIBUTION OF THE DROSOPHILA INITIATOR SEQUENCE TO RNA POLYMERASE PAUSING. SHAO W, ALCANTARA SG, ZEITLINGER J. ELIFE. 2019;8:E41461. DOI: 41410.47554/ELIFE.41461. 52. TRANSLATION AFFECTS MRNA STABILITY IN A CODON-DEPENDENT MANNER IN HUMAN CELLS. WU Q, MEDINA SG, KUSHAWAH G, DEVORE ML, CASTELLANO LA, HAND JM, WRIGHT M, BAZZINI AA. ELIFE. 2019;8:E45396. DOI: 45310.47554/ELIFE.45396. 53. SET1-CATALYZED H3K4 TRIMETHYLATION ANTAGONIZES THE HIR/ASF1/RTT106 REPRESSOR COMPLEX TO PROMOTE HISTONE GENE EXPRESSION AND CHRONOLOGICAL LIFE SPAN. MEI Q, XU C, GOGOL M, TANG J, CHEN W, YU X, WORKMAN JL, LI S. NUCLEIC ACIDS RES. 2019;47:3434-3449. 54. EVALUATING CHROMATOGRAPHIC APPROACHES FOR THE QUANTITATIVE ANALYSIS OF A HUMAN PROTEOME ON ORBITRAP-BASED MASS SPECTROMETRY SYSTEMS. ZHANG Y, WEN Z, WASHBURN MP, FLORENS L. J PROTEOME RES. 2019;18:1857-1869. 55. DISTRIBUTION OF PROTEINS AT THE INNER NUCLEAR MEMBRANE IS REGULATED BY THE ASI1 E3 LIGASE IN SACCHAROMYCES CEREVISIAE. SMOYER CJ, SMITH SE, GARDNER JM, MCCROSKEY S, UNRUH JR, JASPERSEN SL. GENETICS. 2019;211:1269-1282. 56. DYRK1A REGULATES THE RECRUITMENT OF 53BP1 TO THE SITES OF DNA DAMAGE IN PART THROUGH INTERACTION WITH RNF169. MENON VR, ANANTHAPADMANABHAN V, SWANSON S, SAINI S, SESAY F, YAKOVLEV V, FLORENS L, DECAPRIO JA, WASHBURN MP, DOZMOROV M, LITOVCHICK L. CELL CYCLE. 2019;18:531-551. 57. A HOX-TALE REGULATORY CIRCUIT FOR NEURAL CREST PATTERNING IS CONSERVED ACROSS VERTEBRATES. PARKER HJ, DE KUMAR B, GREEN SA, PRUMMEL KD, HESS C, KAUFMAN CK, MOSIMANN C, WIEDEMANN LM, BRONNER ME, KRUMLAUF R. NAT COMMUN. 2019;10:1189. DOI: 1110.1038/S41467-41019-09197-41468. 58. TOPOLOGICAL SCORING OF PROTEIN INTERACTION NETWORKS. SARDIU ME, GILMORE JM, GROPPE BD, DUTTA A, FLORENS L, WASHBURN MP. NAT COMMUN. 2019;10:1118. DOI: 1110.1038/S41467-41019-09123-Y. 59. IMAGING-BASED ASSAYS FOR INVESTIGATING FUNCTIONS OF THE RNA POLYMERASE II ELONGATION FACTOR ELONGIN AND THE ELONGIN UBIQUITIN LIGASE. WEEMS JC, UNRUH JR, SLAUGHTER BD, CONAWAY RC, CONAWAY JW. METHODS. 2019;159-160:157-164. 60. CHARACTERIZATION OF A METAZOAN ADA ACETYLTRANSFERASE COMPLEX. SOFFERS JHM, LI X, SARAF A, SEIDEL CW, FLORENS L, WASHBURN MP, ABMAYR SM, WORKMAN JL. NUCLEIC ACIDS RES. 2019;47:3383-3394. 61. A CHEMOPROTEOMIC PORTRAIT OF THE ONCOMETABOLITE FUMARATE. KULKARNI RA, BAK DW, WEI D, BERGHOLTZ SE, BRINEY CA, SHRIMP JH, ALPSOY A, THORPE AL, BAVARI AE, CROOKS DR, LEVY M, FLORENS L, WASHBURN MP, FRIZZELL N, DYKHUIZEN EC, WEERAPANA E, LINEHAN WM, MEIER JL. NAT CHEM BIOL. 2019;15:391-400 62. HOST VESICLE FUSION PROTEIN VAPB IS REQUIRED FOR THE NUCLEAR EGRESS STAGE OF HERPES SIMPLEX VIRUS TYPE-1 (HSV-1) REPLICATION. SAIZ-ROS N, CZAPIEWSKI R, EPIFANO I, STEVENSON A, SWANSON SK, DIXON CR, ZAMORA DB, MCELWEE M, VIJAYAKRISHNAN S, RICHARDSON CA, DONG L, KELLY DA, PYTOWSKI L, GOLDBERG MW, FLORENS L, GRAHAM SV, SCHIRMER EC. CELLS. 2019;8 E120. DOI: 110.3390/CELLS8020120. 63. TOWARDS THE MOLECULAR DECIPHERING OF POMACEA CANALICULATA IMMUNITY: FIRST PROTEOMIC ANALYSIS OF CIRCULATING HEMOCYTES. BORALDI F, LOFARO FD, ACCORSI A, ROSS E, MALAGOLI D. PROTEOMICS. 2019;19:E1800314. DOI: 1800310.1801002/PMIC.XXX-XX-XXXX. 64. DEFINING GENE NETWORKS CONTROLLING THE MAINTENANCE AND FUNCTION OF THE DIFFERENTIATION NICHE BY AN IN VIVO SYSTEMATIC RNAI SCREEN. GAO Y, MAO Y, XU RG, ZHU R, ZHANG M, SUN J, SHEN D, PENG P, XIE T, NI JQ. J GENET GENOME. 2019;46:19-30. 65. SCRNA-SEQ REVEALS DISTINCT STEM CELL POPULATIONS THAT DRIVE HAIR CELL REGENERATION AFTER LOSS OF FGF AND NOTCH SIGNALING. LUSH ME, DIAZ DC, KOENECKE N, BAEK S, BOLDT H, ST PETER MK, GAITAN-ESCUDERO T, ROMERO-CARVAJAL A, BUSCH-NENTWICH EM, PERERA AG, HALL KE, PEAK A, HAUG JS, PIOTROWSKI T. ELIFE. 2019;8:E44431. DOI: 44410.47554/ELIFE.44431. 66. N-CADHERIN-EXPRESSING BONE AND MARROW STROMAL PROGENITOR CELLS MAINTAIN RESERVE HEMATOPOIETIC STEM CELLS. ZHAO M, TAO F, VENKATRAMAN A, LI Z, SMITH SE, UNRUH J, CHEN S, WARD C, QIAN P, PERRY JM, MARSHALL H, WANG J, HE XC, LI L. CELL REP. 2019;26:652-669 E656. 67. THE DROSOPHILA DBF4 ORTHOLOG CHIFFON FORMS A COMPLEX WITH GCN5 THAT IS NECESSARY FOR HISTONE ACETYLATION AND VIABILITY. TORRES-ZELADA EF, STEPHENSON RE, ALPSOY A, ANDERSON BD, SWANSON SK, FLORENS L, DYKHUIZEN EC, WASHBURN MP, WEAKE VM. J CELL SCI. 2019;132:JCS.214072. 68. ELECTROPORATION OF SHORT HAIRPIN RNAS FOR RAPID AND EFFICIENT GENE KNOCKDOWN IN THE STARLET SEA ANEMONE, NEMATOSTELLA VECTENSIS. KARABULUT A, HE S, CHEN CY, MCKINNEY SA, GIBSON MC. DEV BIOL. 2019;448:7-15. 69. OOCYTE-SPECIFIC DELETION OF HDAC8 IN MICE REVEALS STAGE-SPECIFIC EFFECTS ON FERTILITY. SINGH VP, YUEH WT, GERTON JL, DUNCAN FE. REPRODUCTION. 2019;157:305-316. 70. NARYA, A RING FINGER DOMAIN-CONTAINING PROTEIN, IS REQUIRED FOR BOTH MEIOTIC DNA DOUBLE-STRAND BREAK FORMATION AND CROSSOVER MATURATION IN DROSOPHILA MELANOGASTER. LAKE CM, NIELSEN RJ, BONNER AM, ECHE S, WHITE-BROWN S, MCKIM KS, HAWLEY RS. PLOS GENET. 2019;15:E1007886. DOI:1007810.1001371/JOURNAL.PGEN.1007886.
71. SHH PLAYS AN INHIBITORY ROLE IN CUSP PATTERNING BY REGULATION OFSOSTDC1. KIM J, AHN Y, ADASOORIYA D, WOO EJ, KIM HJ, HU KS, KRUMLAUF R, CHO SW. J DENT RES. 2019;98:98-106. 72. FUNCTIONAL CONSEQUENCES OF THE EVOLUTION OF MATRIMONY, A MEIOSIS-SPECIFIC INHIBITOR OF POLO KINASE. BONNER AM, HAWLEY RS. MOL BIOL EVOL. 2019;36:69-83. 73. GLYCOLYSIS REGULATES GENE EXPRESSION BY PROMOTING THE CROSSTALK BETWEEN H3K4 TRIMETHYLATION AND H3K14 ACETYLATION IN SACCHAROMYCES CERVISIAE. WU Y, ZHANG S, GONG X, YU Q, ZHANG Y, LUO M, ZHANG X, WORMAN JL, YU X, LI S. J GENET GENOMICS. 2019;46:561-574. 74. UNIDIRECTIONAL PROPULSION OF PLANAR MAGNETIC NANOMACHINES. COHEN K-J, RUBINSTEIN BY, KENNETH O, LESHANSKY AM. PHYS REV APPLIED. 2019;12:014025:1-10. REVIEWS, COMMENTARIES, CHAPTERS, AND BOOKS 1. CONTINUING THE ADVANCEMENT OF JOURNAL OF HISTOTECHNOLOGY - ONE ISSUE AT A TIME. WANG Y. J HISTOTECHNOL. 2019;42:165-166. 2. EXOGENOUS PYRUVATE REPRESSES HISTONE GENE EXPRESSION AND INHIBITS CANCER CELL PROLIFERATION VIA THE NAMPT-NAD+-SIRT1 PATHWAY. MA R, WU Y, ZHAI Y, HU B, MA W, YANG W, YU Q, CHEN Z, WORKMAN JL, YU X, LI S. NUCLEIC ACIDS RES. 2019;47:11132-11150. 3. THE JOY OF BALANCERS. MILLER DE, COOK KR, HAWLEY RS. PLOS GENET. 2019;15:E1008421. DOI: 1008410.1001371/JOURNAL.PGEN.1008421. 4. REBOOTING THE EPIGENOME: ERASURE OF PARENTAL HISTONE MARKS FOR ESTABLISHING THE REGULATORY LANDSCAPE IN ZYGOTES. BHATTACHARYA S, WORKMAN JL. [PUBLISHED AHEAD OF PRINT OCTOBER 23 2019]. BIOCHEMISTRY. 2019. 5. BEYOND BASIC AT THE STOWERS INSTITUTE FOR MEDICAL RESEARCH. BLAND K, ORR AA. MO MED. 2019;116:457-460. 6. AN INTERDISCIPLINARY APPROACH TO INVESTIGATE COLLECTIVE CELL MIGRATION IN NEURAL CREST. GINIUNAITE R, MCLENNAN R, MCKINNEY MC, BAKER RE, KULESA PM, MAINI PK. [PUBLISHED AHEAD OF PRINT OCTOBER 18 2019]. DEV DYN. 2019. 7. PURIFICATION AND ENZYMATIC ASSAY OF CLASS I HISTONE DEACETYLASE ENZYMES. ADAMS MK, BANKS CAS, MIAH S, KILLER M, WASHBURN MP. METHODS ENZYMOL. 2019;626:23-40. 8. COMPARING SENSORY ORGANS TO DEFINE THE PATH FOR HAIR CELL REGENERATION. DENANS N, BAEK S, PIOTROWSKI T. ANNU REV CELL DEV BIOL. 2019;35:568-589. 9. NSL COMPLEX ACETYLATES LAMIN A/C. POPOVA VV, WORKMAN JL. NAT CELL BIOL. 2019;21:1177-1178. 10. PATROLLING THE NUCLEUS: INNER NUCLEAR MEMBRANE-ASSOCIATED DEGRADATION. SMOYER CJ, JASPERSEN SL. CURR GENET. 2019;65:1099-1106. 11. THE HUNT FOR RNA POLYMERASE II ELONGATION FACTORS: A HISTORICAL PERSPECTIVE. CONAWAY RC, CONAWAY JW. NAT STRUCT MOL BIOL. 2019;26:771-776. 12. REGULATION OF GENOMIC OUTPUT AND (PLURI)POTENCY IN REGENERATION. DUNCAN EM, SNCHEZ ALVARADO A. ANNU REV GENET. 2019;53:16.1-16.20. 13. CNIDOFEST 2018: THE FUTURE IS BRIGHT FOR CNIDARIAN RESEARCH. HE S, GRASIS JA, NICOTRA ML, JULIANO CE, SCHNITZLER CE. EVODEVO. 2019;10:20. DOI: 10.1186/S13227-13019-10134-13225. 14. HISTONE LYSINE DE-BETA-HYDROXYBUTYRYLATION BY SIRT3. ABMAYR SM, WORKMAN JL. CELL RES. 2019;29:694-695. 15. GENE CONVERSION GENERATES EVOLUTIONARY NOVELTY THAT FUELS GENETIC CONFLICTS. DAUGHERTY MD, ZANDERS SE. V.CURR OPIN GENET DE 2019;58:49-54. 16. A FAMILY OF KILLERS. DE CARVALHO M, ZANDERS SE. ELIFE. 2019;8:E46454. DOI: 46410.47554/ELIFE.46454. 17. WHEN MOTHERS LEAVE THEIR MARK. BARAJAS-AZPELETA R, SI K. ELIFE. 2019;8:E48899. DOI:48810.47554/ELIFE.48899. 18. HEMATOPOIETIC STEM CELLS: SELF-RENEWAL AND EXPANSION. LI Z, HE XC, LI L. CURR OPIN HEMATOL. 2019;26:258-265. 19. FERTILITY COSTS OF MEIOTIC DRIVERS. ZANDERS SE, UNCKLESS RL. CURR BIOL. 2019;29:R512-R520. 20. CORNELIA DE LANGE SYNDROME, RELATED DISORDERS, AND THE COHESIN COMPLEX: ABSTRACTS FROM THE 8TH BIENNIAL SCIENTIFIC AND EDUCATIONAL SYMPOSIUM 2018. KLINE AD, KRANTZ ID, BANDO M, SHIRAHIGE K, CHEA S, SAKATA T, RAO S, DORSETT D, SINGH VP, GERTON JL, HORSFIELD JA, CALOF AL, KATZ O, GRADOS M, RAIBLE S, BARANANO K, LYON G, MUSIO A, CARRICO CS, CLEMENS DK, CAUDILL P, MASSA V, MCGILL BE, DOMMESTRUP A, O'CONNOR J, HAALAND RE. AM J MED GENET A. 2019;179:1030-1090. 21. HOX GENES: DOWNSTREAM "EFFECTORS" OF RETINOIC ACID SIGNALING IN VERTEBRATE EMBRYOGENESIS. NOLTE C, DE KUMAR B, KRUMLAUF R. GENESIS. 2019:E23306. DOI:10.1002/DVG.23306. 22. NICHE CELLS REWIRED TO MAINTAIN HSCS EX VIVO. VENKATRAMAN A, LI L. NAT CELL BIOL. 2019;21:540-541. 23. COMMENTARY ON "REGENERATION, DUPLICATION AND TRANSDETERMINATION IN FRAGMENTS OF THE LEG DISC OF DROSOPHILA MELANOGASTER": SCHUBIGER, G. (1971). DEV BIOL. 2019;449:63-82.. GIBSON MC. DEV BIOL. 2019;449:63-82. 24. IN OVO ELECTROPORATION OF PLASMID DNA AND MORPHOLINOS INTO SPECIFIC TISSUES DURING EARLY EMBRYOGENESIS. MCLENNAN R, KULESA PM. METHODS MOL BIOL.2019;1976:71-82. 25. MOUSE EMBRYO CULTURE FOR THE STUDY OF NEURAL CREST CELLS. MUNOZ WA, TRAINOR PA. METHODS MOL BIOL: MEIOSIS. 2019;1976:107-119. 26. OBSERVATION OF TWO SEPARATE BIPOLAR SPINDLES IN THE HUMAN ZYGOTE. XU, X., LI L, ZHANG C, MENG L. J ASSIST REPROD GENET. 2019;36:601-602. CORRECTION: J ASSIST REPROD GENET. 2019 JUL 31. PII: 10.1007/S10815-019-01539-1. DOI: 10.1007/S10815-019-01539-1. 27. SWEET FISH: FISH MODELS FOR THE STUDY OF HYPERGLYCEMIA AND DIABETES. KRISHNAN J, ROHNER N. J DIABETES. 2019;11:193-203. 28. RIBOSOMAL DNA INSTABILITY AND GENOME ADAPTABILITY. SALIM D, GERTON JL. CHROMOSOME RES. 2019;27:73-87. 29. RIBOSOMAL DNA AND THE NUCLEOLUS IN THE CONTEXT OF GENOME ORGANIZATION. POTAPOVA TA, GERTON JL. CHROMOSOME RES. 2019;27:109-127. 30. THE SOCIETY FOR CRANIOFACIAL GENETICS AND DEVELOPMENTAL BIOLOGY 41ST ANNUAL MEETING. TANEYHILL LA, MOODY SA, COX T, KLEIN OD, MARCUCIO R, SCHNEIDER RA, TRAINOR PA. AM J MED GENET A. 2019;179:864-869. 31. MANIPULATION OF DEVELOPMENTAL FUNCTION IN TURTLES WITH NOTES ON ALLIGATORS. MOUSTAKAS-VERHO JE, MCLENNAN R, SPENGLER J, KULESA PM, CEBRA-THOMAS JA. METHODS MOL BIOL. 2019;1920:247-263. AUTHOR'S CORRECTION: METHODS MOL BIOL. 2019;1920:C1. 32. AN INTEGRATIVE VIEW OF LEPIDOSAUR CRANIAL ANATOMY, DEVELOPMENT AND DIVERSIFICATION. DIAZ JR. RE, TRAINOR PA. IN: ZIERMANN, D JR., AND DIOGO, EDS. HEADS, JAWS AND MUSCLES ANATOMICAL, FUNCTIONAL AND DEVELOPMENTAL DIVERSITY IN CHORDATE EVOLUTION, SPRINGER; 2019:207-227. 33. RIBOSOMAL DNA-CONNECTING RIBOSOME BIOGENESIS AND CHROMOSOME BIOLOGY. POROKHOVNIK L, GERTON JL. CHROMOSOME RES. 2019;27:1-3. 34. RECENT ADVANCES IN UNDERSTANDING INTESTINAL STEM CELL REGULATION. HU D, YAN H, HE XC, LI L. F1000RES. 2019;8:F1000 FACULTY REV-72. PUBLISHED 2019 JAN 18. DOI:10.12688/F1000RESEARCH.16793.1 COMPETITIVE RESEARCH GRANT FUNDING & RESEARCH AWARDS & DISTINCTIONS THE ABILITY OF SIMR SCIENTISTS TO RECEIVE COMPETITIVELY AWARDED RESEARCH FUNDING ATTESTS TO THE HIGH LEVEL OF RESEARCH PRODUCTIVITY PRESENT AT SIMR. DURING 2019, SIMR SCIENTISTS WORKED WITH THE SUPPORT OF 31 GRANTS AND FELLOWSHIPS FROM THE NATIONAL INSTITUTES OF HEALTH, TWO GRANTS FROM THE NATIONAL SCIENCE FOUNDATION, TWO GRANTS FROM THE MARCH OF DIMES, ONE GRANT FROM THE GREATER KANSAS CITY COMMUNITY FOUNDATION, ONE GRANT FROM THE HEARING HEALTH FOUNDATION, ONE FELLOWSHIP FROM THE JANE COFFIN CHILDS MEMORIAL FUND, ONE AWARD FROM THE SEARLE SCHOLARS PROGRAM, ONE AWARD FROM THE PEW CHARITABLE TRUSTS, ONE AWARD FROM THE UNIVERSITY OF KANSAS ENDOWMENT ASSOCIATION, ONE GRANT FROM THE EDWARD MALLINCKRODT JR. FOUNDATION, ONE GRANT FROM THE JUVENILE DIABETES RESEARCH FOUNDATION, ONE GRANT FROM THE UNIVERSITY OF KANSAS ALZHEIMER'S DISEASE CENTER, ONE GRANT FROM THE UNIVERSITY OF KANSAS CANCER CENTER, AND ONE INVESTIGATOR AWARD FROM THE HOWARD HUGHES MEDICAL INSTITUTE. SUPPORT FROM NEW AND CONTINUING AWARDS TO SIMR TOTALED MORE THAN $6.2 MILLION IN 2019 TO SUPPLEMENT INCOME FROM ITS ENDOWMENTS. TESTIFYING TO THE HIGH LEVEL OF ACHIEVEMENT TAKING PLACE AT SIMR ARE THE AWARDS AND HONORS SIMR MEMBERS RECEIVED IN 2019: 1. NICOLAS ROHNER, PHD, RECEIVED A TWO-YEAR GRANT FROM THE JUVENILE DIABETES RESEARCH FOUNDATION 2. TING XIE, PHD, WAS AWARDED A FIVE-YEAR GRANT FROM THE NIH EUNICE SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH AND HUMAN DEVELOPMENT 3. LINHENG LI, PHD, RECEIVED A FIVE-YEAR GRANT FROM THE NIH NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES 4. ARIEL BAZZINI, PHD, RECEIVED A TWO-YEAR PEW INNOVATION FUND AWARD ALONG WITH COLLABORATOR DIEGO ALVAREZ, PHD, FROM THE NATIONAL UNIVERSITY OF SAN MARTIN, ARGENTINA 5. RANDAL HALFMANN, PHD, RECEIVED A FOUR-YEAR NIH GRANT FROM THE NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES 6. ERIC HILL, PHD, A POSTDOCTORAL RESEARCHER IN THE GIBSON LAB, WAS AWARDED A TWOYEAR NIH FELLOWSHIP FROM THE NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES 7. CASSANDRA KEMPF, A PREDOCTORAL RESEARCHER OF THE GRADUATE SCHOOL OF THE STOWERS INSTITUTE, RECEIVED A THREE-YEAR FELLOWSHIP FROM THE NIH NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES 8. STACEY HANLON, PHD, A POSTDOCTORAL RESEARCHER IN THE HAWLEY LAB, WAS AWARDED A TWO-YEAR GRANT FROM THE NIH EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH AND HUMAN DEVELOPMENT 9. JOSEPH VARBERG, PHD, A POSTDOCTORAL RESEARCHER IN THE JASPERSEN LAB, RECEIVED A ONE-YEAR NIH NRSA POSTDOCTORAL FELLOWSHIP
10. JIANZHENG WU, A UNIVERSITY OF KANSAS MEDICAL CENTER PREDOCTORALRESEARCHER IN THE HALFMANN LAB, WAS AWARDED A ONE-YEAR FELLOWSHIP FROM THE UNIVERSITY OF KANSAS MEDICAL CENTER INSTITUTE FOR NEUROLOGICAL DISCOVERIES INDEPENDENT RESEARCH PROGRAM LEADERS LABORATORIES INDIVIDUAL SCIENTISTS AT THE SIMR SPECIALIZE IN THE STUDY OF ONE OR MORE PARTICULAR GENES, PROTEINS, OR OTHER MOLECULES, EACH OF WHICH MAY CAUSE OR INFLUENCE VARIOUS KINDS OF DISEASE. A COMPREHENSIVE LIST OF RESEARCH LEADERS FOLLOWS: 1. ALEJANDRO SNCHEZ ALVARADO, PHD, SCIENTIFIC DIRECTOR, INVESTIGATOR, AND HOWARD HUGHES MEDICAL INSTITUTE INVESTIGATOR, JOINED SIMR IN 2011 FROM THE UNIVERSITY OF UTAH'S SCHOOL OF MEDICINE, WHERE HE HELD THE H.A. & EDNA BENNING PROFESSORSHIP OF NEUROBIOLOGY AND ANATOMY. HE RECEIVED A BS IN MOLECULAR BIOLOGY AND CHEMISTRY FROM VANDERBILT UNIVERSITY IN NASHVILLE, TENN., AND A PHD IN PHARMACOLOGY AND CELL BIOPHYSICS FROM THE UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE IN CINCINNATI, OHIO. RESEARCH FOCUS: THE MOLECULAR AND CELLULAR MECHANISMS UNDERPINNING ANIMAL REGENERATION USING THE PLANARIAN SCHMIDTEA MEDITERRANEA AS A MODEL SYSTEM. 2. ARIEL BAZZINI, PHD, ASSISTANT INVESTIGATOR, JOINED SIMR IN 2016 FROM THE LAB OF ANTONIO J. GIRALDEZ, PHD, IN THE DEPARTMENT OF GENETICS AT YALE UNIVERSITY, WHERE HE COMPLETED A POSTDOCTORAL FELLOWSHIP. DR. BAZZINI RECEIVED HIS PHD IN MOLECULAR BIOLOGY AT THE UNIVERSITY OF BUENOS AIRES, ARGENTINA. FOR HIS DOCTORAL DISSERTATION, HE STUDIED PLANT GENETICS AT THE INSTITUTE OF BIOTECHNOLOGY IN ARGENTINA'S NATIONAL INSTITUTE OF AGRICULTURAL TECHNOLOGY (INTA). RESEARCH FOCUS: THE REGULATION OF GENE EXPRESSION IN VERTEBRATES. 3. JOAN CONAWAY, PHD, INVESTIGATOR, JOINED SIMR IN 2001 FROM THE OKLAHOMA MEDICAL RESEARCH FOUNDATION WHERE SHE WAS AN ASSOCIATE INVESTIGATOR OF THE HOWARD HUGHES MEDICAL INSTITUTE AND INTERIM HEAD OF THE PROGRAM IN MOLECULAR AND CELL BIOLOGY. DR. CONAWAY RECEIVED HER DOCTORATE IN CELL BIOLOGY FROM STANFORD UNIVERSITY SCHOOL OF MEDICINE. RESEARCH FOCUS: ANALYSIS OF THE MOLECULAR MECHANISM AND REGULATION OF GENE TRANSCRIPTION. 4. RONALD CONAWAY, PHD, INVESTIGATOR, JOINED SIMR IN 2001 FROM THE OKLAHOMA MEDICAL RESEARCH FOUNDATION WHERE HE WAS HOLDER OF THE CHAPMAN CHAIR IN MEDICAL RESEARCH. DR. CONAWAY RECEIVED HIS PHD IN BIOCHEMISTRY FROM STANFORD UNIVERSITY SCHOOL OF MEDICINE. RESEARCH FOCUS: ANALYSIS OF THE MOLECULAR MECHANISM AND REGULATION OF GENE TRANSCRIPTION. 5. JENNIFER GERTON, PHD, INVESTIGATOR, JOINED SIMR IN 2002 FROM A POSTDOCTORAL FELLOWSHIP IN THE LABORATORY OF DR. JOSEPH DERISI IN THE DEPARTMENT OF BIOCHEMISTRY AND BIOPHYSICS AT THE UNIVERSITY OF CALIFORNIA-SAN FRANCISCO. DR. GERTON RECEIVED A PHD IN MICROBIOLOGY AND IMMUNOLOGY FROM STANFORD UNIVERSITY. RESEARCH FOCUS: GENOMIC AND GENETIC ANALYSIS OF CHROMOSOME SEGREGATION AND CHROMOSOME DYNAMICS. 6. MATTHEW GIBSON, PHD, INVESTIGATOR AND DEAN OF THE GRADUATE SCHOOL, JOINED SIMR IN 2006 FROM A JANE COFFIN CHILDS MEMORIAL FUND POSTDOCTORAL FELLOWSHIP WITH DR. NORBERT PERRIMON AT HARVARD MEDICAL SCHOOL. DR. GIBSON RECEIVED A PHD IN ZOOLOGY FROM THE UNIVERSITY OF WASHINGTON. RESEARCH FOCUS: GENETIC ANALYSIS OF MECHANISMS CONTROLLING SIGNAL TRANSDUCTION, CELL PROLIFERATION, AND EPITHELIAL MORPHOGENESIS DURING DROSOPHILA DEVELOPMENT. 7. RANDAL HALFMANN, PHD, ASSISTANT INVESTIGATOR, JOINED SIMR IN 2015 FROM THE UNIVERSITY OF TEXAS (UT) SOUTHWESTERN MEDICAL CENTER. HE RECEIVED A PHD IN BIOLOGY FROM THE MASSACHUSETTS INSTITUTE OF TECHNOLOGY, WHERE HE WAS A NATIONAL SCIENCE FOUNDATION PREDOCTORAL FELLOW. AFTER COMPLETING HIS GRADUATE STUDIES, DR. HALFMANN OBTAINED AN INDEPENDENT POSITION AT UT SOUTHWESTERN MEDICAL CENTER WHERE HE WAS A SARA AND FRANK MCKNIGHT FELLOW AND RECEIVED A DIRECTOR'S EARLY INDEPENDENCE AWARD FROM THE NATIONAL INSTITUTES OF HEALTH. RESEARCH FOCUS: CELLULAR AND EVOLUTIONARY IMPLICATIONS OF PROTEIN SELF-ASSEMBLY USING GENETIC, BIOCHEMICAL, AND CELL-BIOLOGICAL APPROACHES. 8. R. SCOTT HAWLEY, PHD, INVESTIGATOR AND DEAN EMERITUS OF THE GRADUATE SCHOOL, JOINED SIMR IN 2001 FROM THE UNIVERSITY OF CALIFORNIA-DAVIS WHERE HE WAS A PROFESSOR OF GENETICS IN THE MOLECULAR AND CELLULAR BIOLOGY SECTION. DR. HAWLEY EARNED A PHD IN GENETICS FROM THE UNIVERSITY OF WASHINGTON AND COMPLETED POSTDOCTORAL TRAINING AS A HELEN HAY WHITNEY FELLOW AT THE INSTITUTE FOR CANCER RESEARCH IN PHILADELPHIA. RESEARCH FOCUS: INVESTIGATION OF MECHANISMS THAT INFLUENCE HOW CHROMOSOMES PAIR AND SEGREGATE DURING MEIOSIS USING DROSOPHILA AS AN EXPERIMENTAL SYSTEM. 9. SUE JASPERSEN, PHD, ASSOCIATE INVESTIGATOR, JOINED SIMR IN 2005 FROM THE LABORATORY OF DR. MARK WINEY AT THE UNIVERSITY OF COLORADO-BOULDER WHERE SHE WAS A KECK FOUNDATION FELLOW, A HELEN HAY WHITNEY FELLOW, AND THE RECIPIENT OF A LEUKEMIA & LYMPHOMA SOCIETY CAREER DEVELOPMENT AWARD. DR. JASPERSEN HOLDS A PHD IN BIOCHEMISTRY FROM THE UNIVERSITY OF CALIFORNIA-SAN FRANCISCO. RESEARCH FOCUS: INNER NUCLEAR MEMBRANE PROTEIN LOCALIZATION AND ROLE IN CHROMOSOME POSITIONING AND SEGREGATION. 10. ROBERT KRUMLAUF, PHD, SCIENTIFIC DIRECTOR EMERITUS AND INVESTIGATOR, JOINED THE SIMR IN 2000 FROM ENGLAND'S NATIONAL INSTITUTE FOR MEDICAL RESEARCH, THE RIDGEWAY, MILL HILL, LONDON, WHERE HE WAS HEAD OF THE DIVISION OF DEVELOPMENTAL NEUROBIOLOGY. DR. KRUMLAUF RECEIVED A PHD IN DEVELOPMENTAL BIOLOGY FROM OHIO STATE UNIVERSITY. RESEARCH FOCUS: ANALYSIS OF MOLECULAR PATHWAYS THAT REGULATE HOW THE MAMMALIAN HEAD, BRAIN AND NERVOUS SYSTEM ARE BUILT, USING A VARIETY OF VERTEBRATE MODEL SYSTEMS. 11. LINHENG LI, PHD, INVESTIGATOR, JOINED SIMR IN 2000 FROM THE UNIVERSITY OF WASHINGTON MEDICAL CENTER WHERE HE HELD A FACULTY APPOINTMENT AFTER COMPLETING POSTDOCTORAL TRAINING IN THE LABORATORY DIRECTED BY DR. LEROY HOOD. DR. LI EARNED HIS PHD IN MOLECULAR AND CELLULAR BIOLOGY FROM NEW YORK UNIVERSITY MEDICAL SCHOOL UNDER THE MENTORING OF DR. EDWARD ZIFF. RESEARCH FOCUS: INVESTIGATION OF MOLECULAR AND GENETIC PATHWAYS CONTROLLING ADULT STEM CELL DEVELOPMENT IN THE HEMATOPOIETIC AND INTESTINAL SYSTEMS USING TRANSGENIC AND GENE TARGETING ANIMAL MODEL APPROACHES. 12. TATJANA PIOTROWSKI, PHD, INVESTIGATOR, JOINED SIMR IN 2011 FROM THE UNIVERSITY OF UTAH'S SCHOOL OF MEDICINE, WHERE SHE WAS AN ASSOCIATE PROFESSOR IN THE DEPARTMENT OF NEUROBIOLOGY AND ANATOMY. SHE RECEIVED HER MASTER'S DEGREE FROM THE UNIVERSITY OF TUBINGEN, GERMANY, AND HER DOCTORATE DEGREE FROM THE MAX PLANCK INSTITUTE FOR DEVELOPMENTAL BIOLOGY IN TUBINGEN. RESEARCH FOCUS: COLLECTIVE CELL MIGRATION, CELL TYPE SPECIFICATION AND STEM CELL BIOLOGY IN ZEBRAFISH AS A MODEL SYSTEM. 13. NICOLAS ROHNER, PHD, ASSISTANT INVESTIGATOR, JOINED SIMR IN 2015 FROM HARVARD MEDICAL SCHOOL, WHERE HE WAS A POSTDOCTORAL FELLOW IN DR. CLIFF TABIN'S LABORATORY. HE EARNED A PHD IN BIOLOGY FROM THE MAX PLANCK INSTITUTE FOR DEVELOPMENTAL BIOLOGY IN TUBINGEN, GERMANY. RESEARCH FOCUS: GENETIC MECHANISMS AND MUTATIONS THAT UNDERLIE THE ANIMAL KINGDOM'S TREMENDOUS DIVERSITY IN MORPHOLOGY, PHYSIOLOGY, AND BEHAVIOR. 14. KAUSIK SI, PHD, ASSOCIATE SCIENTIFIC DIRECTOR AND INVESTIGATOR, JOINED SIMR IN 2005FROM THE LABORATORY OF DR. ERIC KANDEL AT COLUMBIA UNIVERSITY CENTER FOR NEUROBIOLOGY AND BEHAVIOR WHERE HE WAS A JANE COFFIN CHILDS FELLOW AND A FRANCIS GOELET FELLOW IN NEUROSCIENCE. DR. SI EARNED A PHD IN MOLECULAR BIOLOGY FROM THE ALBERT EINSTEIN COLLEGE OF MEDICINE. RESEARCH FOCUS: ROLE OF SYNAPTIC PROTEIN SYNTHESIS IN INFORMATION ACQUISITION AND MEMORY STORAGE. 15. PAUL TRAINOR, PHD, INVESTIGATOR, JOINED SIMR IN 2001 FROM A RESEARCH POSITION AT THE NATIONAL INSTITUTE FOR MEDICAL RESEARCH AT MILL HILL, LONDON, WHERE HE COMPLETED POSTDOCTORAL TRAINING. DR. TRAINOR HAS A PHD IN DEVELOPMENTAL BIOLOGY FROM CHILDREN'S MEDICAL RESEARCH INSTITUTE AT THE UNIVERSITY OF SYDNEY, AUSTRALIA. RESEARCH FOCUS: INVESTIGATION OF THE INTERACTIONS BETWEEN DISTINCT TISSUES IN THE BODY AND THEIR REGULATION DURING NORMAL DEVELOPMENT TO REVEAL PATHWAYS THAT REGULATE NORMAL CRANIAL AND FACIAL DEVELOPMENT. 16. JERRY WORKMAN, PHD, INVESTIGATOR, JOINED SIMR IN 2003 FROM THE PENNSYLVANIA STATE UNIVERSITY WHERE HE HELD THE PAUL BERG PROFESSORSHIP OF BIOCHEMISTRY AND WAS AN ASSOCIATE INVESTIGATOR OF THE HOWARD HUGHES MEDICAL INSTITUTE. DR. WORKMAN EARNED A PHD IN CELL AND MOLECULAR BIOLOGY FROM THE UNIVERSITY OF MICHIGAN AND COMPLETED POSTDOCTORAL TRAINING AT THE ROCKEFELLER UNIVERSITY WITH DR. BOB ROEDER. RESEARCH FOCUS: STUDY OF THE PROTEIN COMPLEXES THAT MODIFY CHROMATIN. 17. TING XIE, PHD, INVESTIGATOR, JOINED SIMR IN 2000 AFTER COMPLETING A HOWARD HUGHES MEDICAL INSTITUTE POSTDOCTORAL FELLOWSHIP IN THE LABORATORY OF DR. ALLAN C. SPRADLING AT THE CARNEGIE INSTITUTION OF WASHINGTON. DR. XIE RECEIVED HIS PHD FROM THE JOINT GRADUATE PROGRAM IN MOLECULAR BIOLOGY AND BIOCHEMISTRY OF RUTGERS UNIVERSITY AND THE UNIVERSITY OF MEDICINE AND DENTISTRY OF NEW JERSEY. RESEARCH FOCUS: GENETIC AND MOLECULAR ANALYSIS OF STEM CELLS AND GERM CELL DEVELOPMENT IN DROSOPHILA AND MOUSE.
18. C. RON YU, PHD, INVESTIGATOR, JOINED SIMR IN 2005 FROM THE LABORATORYOF DR. RICHARD AXEL AT COLUMBIA UNIVERSITY CENTER FOR NEUROBIOLOGY AND BEHAVIOR WHERE HE HELD A NATIONAL INSTITUTES OF HEALTH MENTORED RESEARCH SCIENTIST AWARD FROM THE NATIONAL INSTITUTE OF MENTAL HEALTH. DR. YU EARNED HIS PHD IN MOLECULAR, CELLULAR, AND BIOPHYSICAL STUDIES AT COLUMBIA UNIVERSITY. RESEARCH FOCUS: HOW OLFACTORY SENSORY INFORMATION IS DETECTED, INTEGRATED, AND PROCESSED IN THE BRAIN TO INFLUENCE SPECIFIC INNATE BEHAVIORS. 19. SARAH ZANDERS, PHD, ASSISTANT INVESTIGATOR AND VICE DEAN OF THE GRADUATE SCHOOL, JOINED SIMR IN 2016 AFTER COMPLETION OF HER POSTDOCTORAL TRAINING IN BASIC SCIENCES AT THE FRED HUTCHINSON CANCER RESEARCH CENTER (FHCRC) WITH SUPPORT FROM A PATHWAY TO INDEPENDENCE AWARD FROM THE NATIONAL INSTITUTES OF HEALTH. FHCRC FACULTY MEMBERS HARMIT S. MALIK, PHD, AND GERRY SMITH, PHD, ADVISED HER RESEARCH ON FERTILITY, GENOME EVOLUTION, AND THE ORIGIN OF NEW SPECIES. DR. ZANDERS RECEIVED HER PHD IN GENETICS AND DEVELOPMENT FROM CORNELL UNIVERSITY. RESEARCH FOCUS: THE EFFECTS OF GENETIC CONFLICTS CAUSED BY SELFISH GENES THAT ARE EMBEDDED IN EUKARYOTIC GENOMES. 20. JULIA ZEITLINGER, PHD, INVESTIGATOR, JOINED SIMR IN 2007 FROM THE LAB OF DR. RICHARD YOUNG AT THE WHITEHEAD INSTITUTE FOR BIOMEDICAL RESEARCH AT MASSACHUSETTS INSTITUTE OF TECHNOLOGY WHERE SHE WAS THE RECIPIENT OF A LONG-TERM POSTDOCTORAL FELLOWSHIP FROM THE HUMAN FRONTIER SCIENCE PROGRAM. DR. ZEITLINGER EARNED A PHD IN MOLECULAR BIOLOGY FROM THE EUROPEAN MOLECULAR BIOLOGY LABORATORY IN HEIDELBERG, GERMANY. RESEARCH FOCUS: ANALYSIS OF THE GENE REGULATORY NETWORKS UNDERLYING CELLULAR DIFFERENTIATION. TECHNOLOGY CENTERS 1. PAUL KULESA, PHD, DIRECTOR OF IMAGING, JOINED SIMR IN 2002 AFTER COMPLETING A BURROUGHS WELLCOME FUND POSTDOCTORAL FELLOWSHIP IN THE LABORATORY OF DR. SCOTT E. FRASER AT THE CALIFORNIA INSTITUTE OF TECHNOLOGY. DR. KULESA RECEIVED A PHD IN APPLIED MATHEMATICS UNDER DR. J.D. MURRAY AT THE UNIVERSITY OF WASHINGTON. RESEARCH FOCUS: CELL MIGRATION IN DEVELOPMENT AND CANCER. 2. MICHAEL WASHBURN, PHD, DIRECTOR OF PROTEOMICS, JOINED SIMR IN 2003 FROM THE TORREY MESA RESEARCH INSTITUTE IN SAN DIEGO WHERE HE WAS A SENIOR STAFF SCIENTIST IN PROTEOMICS. HE EARNED A PHD IN BIOCHEMISTRY AND ENVIRONMENTAL TOXICOLOGY FROM MICHIGAN STATE UNIVERSITY BEFORE COMPLETING A POSTDOCTORAL FELLOWSHIP WITH PROFESSOR JOHN YATES, III IN THE DEPARTMENT OF MOLECULAR BIOTECHNOLOGY AT THE UNIVERSITY OF WASHINGTON. RESEARCH FOCUS: QUANTITATIVE PROTEOMICS AND PROTEIN COMPLEX DYNAMICS.

Schedule R IRS990ScheduleR

Id Related Tax Exempt Org IdRelatedTaxExemptOrgGrp (6 entries)

Address Line1USAddress/AddressLine1TxtCityUSAddress/CityNmState AbbreviationUSAddress/StateAbbreviationCdZIPUSAddress/ZIPCdEINEINPrimary ActivitiesPrimaryActivitiesTxtLegal Domicile StateLegalDomicileStateCdExempt Code SectionExemptCodeSectionTxtPublic Charity StatusPublicCharityStatusTxtBusiness Name Line1DirectControllingEntityName/BusinessNameLine1TxtControlled OrganizationControlledOrganizationInd
STOWERS SCIENTIFIC EDUCATION INSTITUTE
1000 EAST 50TH STREETKANSAS CITYMO64110205916445SUPPORT ORGDE501(C)(3)12A, ISIMRYes (true)
STOWERS RESOURCE MANAGEMENTINC
1000 EAST 50TH STREETKANSAS CITYMO64110412186719SUPPORT ORGDE501(C)(3)12A, ISIMRYes (true)
BIOMED VALLEY CORPORATION
1000 EAST 50TH STREETKANSAS CITYMO64110743238244SUPPORT ORGDE501(C)(3)12A, ISIMRYes (true)
STOWERS REAL ESTATE HOLDING CORPORATION
1000 EAST 50TH STREETKANSAS CITYMO64110261472230TITLE HOLDINGDE501(C)(2)N/ASRMYes (true)
STOWERS POLICY INSTITUTE INC
100O EAST 50TH STREETKANSAS CITYMO64110203270502SEE PART VIIDE501(C)(4)N/ASIMRYes (true)
THE GRADUATE SCHOOL OF SIMR
1000 EAST 50TH STREETKANSAS CITYMO64110464588696EDUCATIONMO501(C)(3)2SIMRYes (true)

Id Related Org Txbl Corp Tr IdRelatedOrgTxblCorpTrGrp

Related Organization Name RelatedOrganizationName

FieldValueIRS element (for citing)
Business Name Line1BIOMED VALLEY DISCOVERIESINCBusinessNameLine1Txt

US Address USAddress

FieldValueIRS element (for citing)
Address Line11000 EAST 50TH STREETAddressLine1Txt
CityKANSAS CITYCityNm
State AbbreviationMOStateAbbreviationCd
ZIP64110ZIPCd
FieldValueIRS element (for citing)
EIN061646533EIN
Primary ActivitiesSEE PART VIIPrimaryActivitiesTxt
Legal Domicile StateDELegalDomicileStateCd

Direct Controlling Entity Name DirectControllingEntityName

FieldValueIRS element (for citing)
Business Name Line1BVCBusinessNameLine1Txt
FieldValueIRS element (for citing)
Entity TypeC CORPEntityTypeTxt
Share Of Total Income$0ShareOfTotalIncomeAmt
Share Of EOY Assets$0ShareOfEOYAssetsAmt
Controlled OrganizationYes (true)ControlledOrganizationInd
FieldValueIRS element (for citing)
Receipt Of Int Annts Rnts RyltsYes (true)ReceiptOfIntAnntsRntsRyltsInd
Gift Grnt Or Cap Contri To Oth OrgfalseGiftGrntOrCapContriToOthOrgInd
Gift Grnt Cap Contri From Oth OrgYes (true)GiftGrntCapContriFromOthOrgInd
Loans Or Guarantees To Other OrgfalseLoansOrGuaranteesToOtherOrgInd
Loans Or Guarantees From Oth OrgfalseLoansOrGuaranteesFromOthOrgInd
Div Related OrganizationfalseDivRelatedOrganizationInd
Asset Sale To Other OrgfalseAssetSaleToOtherOrgInd
Asset Purchase From Other OrgfalseAssetPurchaseFromOtherOrgInd
Asset ExchangefalseAssetExchangeInd
Rental Of Facilities To Oth OrgYes (true)RentalOfFacilitiesToOthOrgInd
Rental Of Fclts From Oth OrgYes (true)RentalOfFcltsFromOthOrgInd
Perform Of Services For Oth OrgfalsePerformOfServicesForOthOrgInd
Perform Of Services By Other OrgfalsePerformOfServicesByOtherOrgInd
Sharing Of FacilitiesYes (true)SharingOfFacilitiesInd
Paid Employees SharingYes (true)PaidEmployeesSharingInd
Reimbursement Paid To Other OrgYes (true)ReimbursementPaidToOtherOrgInd
Reimbursement Paid By Other OrgYes (true)ReimbursementPaidByOtherOrgInd
Transfer To Other OrgYes (true)TransferToOtherOrgInd
Transfer From Other OrgfalseTransferFromOtherOrgInd

Transactions Related Org TransactionsRelatedOrgGrp (10 entries)

Transaction TypeTransactionTypeTxtInvolvedInvolvedAmtMethod Of Amount DeterminationMethodOfAmountDeterminationTxt
BIOMED VALLEY DISCOVERIES INC
A$755,726MARKET VALUE
BIOMED VALLEY DISCOVERIES INC
A$15,304MARKET VALUE
STOWERS RESOURCE MANAGEMENT INC
C$63,000,000MARKET VALUE
STOWERS REAL ESTATE HOLDING CORP
K$2,230,551MARKET VALUE
STOWERS RESOURCE MANAGEMENT INC
P$26,810,693COST REIMB.
THE GRADUATE SCHOOL OF SIMR
P$1,217,267COST REIMB.
BIOMED VALLEY DISCOVERIES INC
P$342,202COST REIMB.
BIOMED VALLEY DISCOVERIES INC
Q$429,034COST REIMB.
THE GRADUATE SCHOOL OF SIMR
R$1,285,700MARKET VALUE
SEE PART VII FOR ADDITIONAL INFORMATION

Supplemental Information Detail SupplementalInformationDetail (12 entries)

Form And Line ReferenceFormAndLineReferenceDescExplanationExplanationTxt
PART II, LINE (5), COLUMN B:STOWERS POLICY INSTITUTE INC'S. ("SPI") PRIMARY ACTIVITY IS TO PROMOTE INNOVATIVE AND ETHICAL BIOMEDICAL RESEARCH, THERAPIES AND CURES, AND TO ADVOCATE FOR A POLITICAL, ECONOMIC AND SOCIAL ENVIRONMENT THAT ADVANCES, FACILITIES, AND PROTECTS THAT RESEARCH AND THOSE THERAPIES AND CURES.
PART IV, LINE (1), COLUMN B:BIOMED VALLEY DISCOVERIES, INC.'S ("BVD") PRIMARY ACTIVITY IS THE DEVELOPMENT AND MARKETING OF SCIENTIFIC DISCOVERIES. BIOMED VALLEY CORPORATION ("BVC") IS THE 100% OWNER OF BVD STOCK.
PART V, LINE 2 (1) BVD:SIMR RECEIVES ROYALTY PAYMENTS FROM BVD PURSUANT TO A LICENSED TECHNOLOGY AGREEMENT DATED JANUARY 29, 2006. THESE ROYALTY PAYMENTS DO NOT CONSTITUTE GROSS INCOME DERIVED FROM AN UNRELATED TRADE OR BUSINESS UNDER SECTION 512(B)(13). THE ROYALTY PAYMENTS FROM BVD TO SIMR DO NOT REDUCE BVD'S TAXABLE INCOME, WHICH WOULD HAVE BEEN UNRELATED BUSINESS INCOME IF BVD WERE EXEMPT UNDER SECTION 501(C)(3) AND HAD THE SAME EXEMPT PURPOSE AS SIMR. IN ADDITION, THE SPECIAL RULE UNDER 512(B)(13)(E) APPLIES.
PART V, LINE 2 (2) BVD:TYPE A, SIMR RECEIVES SUBLEASE PAYMENTS FROM BVD BASED ON COST FOR LESS THAN 300 SQ FT OF SPACE FOR A LIMITED USE PURPOSE. THE RENT PAYMENTS FROM BVD TO SIMR DO NOT REDUCE BVD'S TAXABLE INCOME WHICH WOULD HAVE BEEN UBTI IF BVD WERE EXEMPT UNDER 501(C)(3) AND HAD THE SAME EXEMPT PURPOSE AS SIMR. THEREFORE, NO PORTION OF THE RENT PAYMENTS FROM BVD CONSTITUTES UNRELATED BUSINESS INCOME TO SIMR UNDER SECTION 512(B)(13).
PART V, LINE 2 (3) SRM:TYPE C, SRM PROVIDED FINANCIAL SUPPORT TO SIMR TO BE USED BY SIMR IN FURTHERANCE OF SIMR'S EXEMPT PURPOSE OF CONDUCTING MEDICAL RESEARCH.
PART V, LINE 2, (4) SREHCTYPE K, SIMR ENTERED INTO A LEASE EFFECTIVE JANUARY 1, 2009 WITH SREHC, A 501(C)(2) TAX EXEMPT ORGANIZATION THAT IS A RELATED PARTY TO SIMR. THE LEASE HAS AN ORIGINAL TERM OF 10 YEARS WITH A PROVISION FOR ADDITIONAL OPTION YEARS FOR A 280,000 SQUARE FEET BUILDING. REFLECTS SIMR'S LEASE PAYMENTS TO SREHC IN 2019.
PART V, LINE 2, (5) SRMTYPE P, SIMR REIMBURSED SRM FOR COSTS ASSOCIATED WITH SRM'S ADMINISTRATIVE AND SUPPORT SERVICES PROVIDED TO SIMR. SRM IS A SUPPORTING ORGANIZATION TO SIMR.
PART V, LINE 2, (6) GSSIMRTYPE P, SIMR REIMBURSED GSSIMR FOR CERTAIN STUDENT EXPENSES INCURRED DURING TIME SPENT IN SIMR LABS.
PART V, LINE 2, (7) BVDTYPE P, SIMR REIMBURSED BVD FOR SERVICES ON THE SERVICE COST METHOD.
PART V, LINE 2, (8) BVDTYPE Q, BVD REIMBURSED SIMR FOR SERVICES ON THE SERVICE COST METHOD.
PART V, LINE 2, (9) GSSIMRTYPE R, EACH ACADEMIC YEAR, SIMR PROVIDES GSSIMR WITH AN APPROPRIATION BASED ON A PER CAPITA FUNDING FORMULA RELATED TO THE NUMBER OF ACTIVELY ENROLLED PREDOCTORAL RESEARCHERS AT GSSIMR.
PART V, LINE 2, (10):ALL OTHER TRANSACTIONS FOR LINE 1 WERE BETWEEN 501(C)(3) PUBLIC CHARITIES AND BELOW REPORTING THRESHOLDS.

Comments

Anonymous: no account or email. Up to 2,000 characters, at most one link. Comments are checked automatically; some wait for review.